Coxibs

RX_COXIBS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — M01AH 1 out of 7 registries used, show all original rules.	131771
4. Check minimum number of events Min. number of events 3	131771
5. Include endpoints None	131771
6. Filter based on genotype QC (FinnGen only)	127799

Control definitions (FinnGen only)

Control exclude: RX_NSAID

Extra metadata

First used in FinnGen datafreeze: DF4

NAME	RX_COXIBS
CONTROL_EXCLUDE	RX_NSAID
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	M01AH
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Coxibs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	127799	80087	47712
Unadjusted period prevalence (%)	25.96	28.41	21.86
Median age at first event (years)	50.91	50.25	52.02

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
18577: Matched controls
97804

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M01AC02

ATC

tenoxicam; systemic, rectal

9.3

323.3

560

326

OAB43, ,

SPAT

2.1

322.8

4432

12672

G04CA01

ATC

alfuzosin; oral

2.8

320.9

2098

4235

R05

ICPC

Cough

2.3

319.6

3486

9061

M77.4

ICD-10 Finland

Metatarsalgia

5.5

318.8

829

823

C07AA05

ATC

propranolol; systemic

2.4

318.7

2905

6960

M23.8

ICD-10 Finland

Other internal derangements of knee

8.9

317.1

564

343

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.1

316.4

4548

13223

N02CC04

ATC

rizatriptan; oral

7.8

316.2

617

431

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

6.3

315.3

721

619

C09CA06

ATC

candesartan; oral

2.3

315.1

3220

8128

R52.2

ICD-10 Finland

Other chronic pain

8.5

311.6

570

362

N02AA05

ATC

oxycodone; systemic

2.5

310.7

2694

6296

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

14.5

309.3

426

158

A98

ICPC

Health maint/preventive medicine

2.6

308.7

16828

76949

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

308.4

3084

7702

M75

ICD-10 Finland

Shoulder lesions

7.0

307.9

646

498

M54.2

ICD-10 Finland

Cervicalgia

6.5

307.7

1212

1041

M10.9

ICD-10 Finland

Gout, unspecified

4.1

307.7

1270

1706

R06AX27

ATC

desloratadine; oral

2.8

307.7

4418

9749

M01AB08

ATC

etodolac; oral

17.1

307.7

1015

329

G43.9

ICD-10 Finland

Migraine, unspecified

6.6

307.7

872

725

M77.1

ICD-10 Finland

Lateral epicondylitis

9.2

307.7

1199

730

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

6.5

307.7

1271

1098

L90

ICPC

Osteoarthrosis of knee

8.4

307.7

870

571

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

7.9

307.7

1682

1224

M01AE02

ATC

naproxen; oral, rectal

11.1

307.7

10707

10636

M16.1

ICD-10 Finland

Other primary coxarthrosis

8.4

307.7

2057

1428

R01AD12

ATC

fluticasone furoate; nasal

3.2

307.7

5056

10309

J01DB01

ATC

cefalexin; oral

3.8

307.7

14877

50055

R01AD58

ATC

fluticasone, combinations; nasal

3.4

307.7

3905

7146

NA3BG, ,

SPAT

10.2

307.7

652

348

R42

ICD-10 Finland

Dizziness and giddiness

2.3

307.7

3411

8661

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

15.3

307.7

1869

708

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.5

307.7

1527

1913

M01AH03

ATC

valdecoxib; oral

30.9

307.7

1194

217

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

6.3

307.7

822

708

M48.0

ICD-10 Finland

Spinal stenosis

7.9

307.7

2130

1587

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.7

307.7

2474

5266

M03BX02

ATC

tizanidine; oral

10.2

307.7

11598

13713

A02BC01

ATC

omeprazole; systemic

2.8

307.7

4556

10192

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

11.2

307.7

548

265

N06AA09

ATC

amitriptyline; systemic

6.0

307.7

1414

1334

ZXA05

NOMESCO Finland

Left side

2.5

307.7

3699

8812

R03AK07

ATC

formoterol and budesonide; inhalant

3.0

307.7

3123

6083

R05

ICD-10 Finland

Cough

2.4

307.7

2992

7136

OAA65, ,

SPAT

3.1

307.7

2600

4817

M01AX05

ATC

glucosamine; oral

29.5

307.7

3362

728

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.5

307.7

2820

6537

M01AE52

ATC

naproxen and esomeprazole; oral

23.3

307.7

403

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

8.4

307.7

1724

1174

N02CC03

ATC

zolmitriptan; nasal, oral

8.5

307.7

630

402

X59

ICD-10 Finland

Exposure to unspecified factor

3.2

307.7

3180

5911

G44.2

ICD-10 Finland

Tension-type headache

4.9

307.7

2126

2517

R03DC03

ATC

montelukast; oral

3.0

307.7

2360

4555

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

5.6

307.7

1462

1460

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

6.4

307.7

2114

1925

A01

ICPC

Pain general/multiple sites

4.1

307.7

1478

2006

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

307.7

5477

14804

N02BE01

ATC

paracetamol; systemic, rectal

9.5

307.7

16708

47448

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

6.2

307.7

852

756

M01AH02

ATC

rofecoxib; oral

27.0

307.7

3229

756

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.3

307.7

3458

8715

M01AC01

ATC

piroxicam; systemic, rectal

9.8

307.7

1843

1083

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.5

307.7

3383

8111

R4110

NOMESCO Finland

Physiotherapy

2.2

307.7

4129

11150

J01MA02

ATC

ciprofloxacin; systemic

2.2

307.7

6137

17768

M79.7

ICD-10 Finland

Fibromyalgia

16.8

307.7

520

167

L88

ICPC

Rheumatoid/seropositive arthritis

9.5

307.7

626

356

J01.0

ICD-10 Finland

Acute maxillary sinusitis

3.2

307.7

3718

7090

M01AX17

ATC

nimesulide; oral

12.7

307.7

3944

2026

J01FA10

ATC

azithromycin; systemic

2.9

307.7

9584

26299

G43

ICD-10 Finland

Migraine

7.0

307.7

729

565

M70.6

ICD-10 Finland

Trochanteric bursitis

8.9

307.7

1913

1250

N06AX11

ATC

mirtazapine; oral

3.0

307.7

5772

12666

M53.0

ICD-10 Finland

Cervicocranial syndrome

5.8

307.7

1426

1386

WX320

NOMESCO Finland

Spinalanesthesy

3.3

307.7

3847

7183

M04AA01

ATC

allopurinol; systemic

3.1

307.7

2394

4514

M17.1

ICD-10 Finland

Other primary gonarthrosis

10.2

307.7

3790

2403

A02BC04

ATC

rabeprazole; oral

4.7

307.7

1234

1470

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.9

307.7

1395

1592

D07AC01

ATC

betamethasone; topical

2.1

307.7

5412

15700

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

307.7

7086

22215

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.0

307.7

1351

1887

M01AX01

ATC

nabumetone; oral

20.1

307.7

596

161

M01AB55

ATC

diclofenac, combinations; oral

21.7

307.7

1054

270

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

307.7

5030

13843

P01BA02

ATC

hydroxychloroquine; oral

7.3

307.7

1260

963

M79.6

ICD-10 Finland

Pain in limb

5.3

307.7

8001

12257

L15

ICPC

Knee symptom/complaint

4.7

307.7

4117

5601

E0000UV, ,

ATC

2.0

307.7

6535

20805

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

9.7

307.7

596

334

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.3

307.7

3757

6992

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

13.8

307.7

841

335

J01DA01

ATC

[U] cefalexin

2.4

307.7

10240

32769

J02AC01

ATC

fluconazole; systemic

2.6

307.7

5369

13064

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

11.6

307.7

987

470

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.9

307.7

6284

14631

D07AB02

ATC

hydrocortisone butyrate; topical

2.1

307.7

4411

12533

N02BF01

ATC

gabapentin; oral

8.4

307.7

1391

930

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.0

307.7

1261

1754

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

8.8

307.7

688

428

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

7.8

307.7

8822

10109

G56.0

ICD-10 Finland

Carpal tunnel syndrome

6.6

307.7

2087

1852

M53.1

ICD-10 Finland

Cervicobrachial syndrome

6.4

307.7

1832

1652

J01CA04

ATC

amoxicillin; systemic

2.7

307.7

14338

54414

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

14.2

307.7

1040

406

ZXD10

NOMESCO Finland

Scheduled procedure

2.1

307.7

5595

16566

R52.9

ICD-10 Finland

Pain, unspecified

3.8

307.7

1480

2173

R06AE07

ATC

cetirizine; oral

2.4

307.7

6941

19512

L86

ICPC

Back syndrome with radiating pain

8.0

307.7

962

661

N06AX21

ATC

duloxetine; oral

6.6

307.7

2056

1811

M01AB05

ATC

diclofenac; systemic, rectal

16.0

307.7

12606

11392

R01AD08

ATC

fluticasone; nasal

2.8

307.7

4371

9838

M19.0

ICD-10 Finland

Primary arthrosis of other joints

9.7

307.7

1541

904

SAA01

NOMESCO Finland

Simple examination of mouth

2.1

307.7

11689

43373

M54.6

ICD-10 Finland

Pain in thoracic spine

5.2

307.7

1131

1193

R03AC02

ATC

salbutamol; inhalant

2.9

307.7

9316

25418

R53

ICD-10 Finland

Malaise and fatigue

2.2

307.7

3983

10888

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.1

307.7

4442

12521

N02BF02

ATC

pregabalin; oral

7.1

307.7

955

742

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

26.2

307.7

645

134

J01AA02

ATC

doxycycline; systemic

3.6

307.7

13161

39161

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

12.8

307.7

491

207

NG1AA, ,

SPAT

6.6

307.7

916

764

M01AE01

ATC

ibuprofen; systemic, rectal

10.8

307.7

16269

38601

L13

ICPC

Hip symptom/complaint

5.0

307.7

2835

3415

R01AD09

ATC

mometasone; nasal

3.1

307.7

7386

17182

ACC51

NOMESCO Finland

Release of median nerve

7.3

307.7

991

747

M13.9

ICD-10 Finland

Arthritis, unspecified

6.0

307.7

1343

1261

A02BC05

ATC

esomeprazole; systemic

4.1

307.7

7080

12697

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.6

307.7

8366

23310

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

27.8

307.7

623

122

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

6.9

307.7

1812

1519

R74

ICPC

Upper respiratory infection acute

2.2

307.7

5039

14254

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.4

307.7

3795

9582

A02BC02

ATC

pantoprazole; systemic

4.5

307.7

12399

30056

H02BX01

ATC

methylprednisolone, combinations; systemic

8.4

307.7

753

487

D07AC13

ATC

mometasone; topical

2.2

307.7

4331

11733

L03

ICPC

Low back symptom/complaint

4.7

307.7

5081

7312

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

7.7

307.7

731

519

M54.9

ICD-10 Finland

Dorsalgia, unspecified

6.2

307.7

2342

2222

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

10.8

307.7

2460

1362

A02BA02

ATC

ranitidine; systemic

2.8

307.7

2847

6028

S18

ICPC

Laceration/cut

2.5

307.7

7229

20147

X58

ICD-10 Finland

Exposure to other specified factors

3.6

307.7

2415

3922

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

307.7

4355

12005

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

11.0

307.7

2636

1443

R05FB02

ATC

cough suppressants and expectorants; systemic

2.5

307.7

5341

13662

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.7

307.7

8826

24375

R05FA02

ATC

opium derivatives and expectorants; systemic

2.5

307.7

6107

15867

N03AX16

ATC

[U] pregabalin

7.7

307.7

4575

3980

N02AJ06

ATC

codeine and paracetamol; systemic

7.1

307.7

8482

10314

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.1

307.7

6591

20374

L28

ICPC

Limited function/disability (L)

2.5

307.7

2713

6246

J01FF01

ATC

clindamycin; systemic

2.6

307.7

4147

9629

L16

ICPC

Ankle symptom/complaint

3.4

307.7

1833

3051

F51.0

ICD-10 Finland

Nonorganic insomnia

3.1

307.7

2523

4726

J01CE02

ATC

phenoxymethylpenicillin; oral

2.3

307.7

11450

39750

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

9.3

307.7

1857

1149

M15

ICD-10 Finland

Polyarthrosis

9.5

307.7

682

390

P01AB01

ATC

metronidazole; oral, rectal

2.4

307.7

5780

15244

M54

ICD-10 Finland

Dorsalgia

6.2

307.7

2394

2263

N05CF02

ATC

zolpidem; oral

3.8

307.7

2630

4022

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

20.1

307.7

436

117

N03AX12

ATC

[U] gabapentin; oral

9.3

307.7

3242

2184

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.1

307.7

2598

3019

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

12.0

307.7

1360

641

J01FA06

ATC

roxithromycin; oral

2.6

307.7

6015

15414

S83.2

ICD-10 Finland

Tear of meniscus, current

6.4

307.7

1022

876

M76.6

ICD-10 Finland

Achilles tendinitis

6.5

307.7

732

611

L12

ICPC

Hand/finger symptom/complaint

3.1

307.7

2532

4788

N02AX02

ATC

tramadol; systemic, rectal

7.2

307.7

8821

10932

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

6.5

307.7

2023

1807

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

13.8

307.7

1035

415

M54.3

ICD-10 Finland

Sciatica

7.7

307.7

855

610

M03BC51

ATC

orphenadrine, combinations; systemic

7.7

307.7

4744

4165

ZXE00

NOMESCO Finland

One hour or less

2.0

307.7

5942

18502

M01AH05

ATC

etoricoxib; oral

137.5

307.7

17029

7247

M02AA07

ATC

piroxicam; topical

6.3

307.7

6251

7254

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

2.1

307.7

8585

27951

M03BC01

ATC

orphenadrine (citrate); systemic

10.2

307.7

4195

2725

G47.3

ICD-10 Finland

Sleep apnoea

3.0

307.7

3200

6439

L01

ICPC

Neck symptom/complaint

3.9

307.7

2428

3651

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

6.5

307.7

734

612

NF1AA

NOMESCO Finland

Hip X-ray examination

3.9

307.7

1285

1832

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.1

307.7

7233

22497

GD1AA, ,

SPAT

3.2

307.7

1663

2898

L04AX03

ATC

methotrexate; systemic

6.6

307.7

1719

1492

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

6.2

307.7

1123

998

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

8.5

307.7

1205

793

L02

ICPC

Back symptom/complaint

3.9

307.7

1613

2305

M54.4

ICD-10 Finland

Lumbago with sciatica

9.1

307.7

3293

2263

R01BA52

ATC

pseudoephedrine, combinations; oral

3.1

307.7

3844

7663

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

10.7

307.7

612

309

H02AB06

ATC

prednisolone; systemic

3.0

307.7

8430

20967

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

9.9

307.7

704

388

L08

ICPC

Shoulder symptom/complaint

4.6

307.7

3524

4749

N05CF01

ATC

zopiclone; oral

2.6

307.7

5137

12671

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

7.5

307.7

675

490

N05BA04

ATC

oxazepam; oral

2.4

307.7

4078

10318

R06.0

ICD-10 Finland

Dyspnoea

2.4

307.7

4167

10556

A06AC01

ATC

ispaghula (psylla seeds); oral

3.2

307.7

4014

7846

M01AB01

ATC

indometacin; systemic, rectal

11.7

307.7

1295

621

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.1

307.7

2629

4980

B01AB05

ATC

enoxaparin; parenteral

2.4

307.7

4674

11855

M01AG02

ATC

tolfenamic acid; oral, rectal

9.9

307.7

1806

1050

L01BA01

ATC

methotrexate; systemic

12.6

307.7

575

247

SPAT1153

SPAT

Removal of sutures

2.2

307.7

4620

12568

L17

ICPC

Foot/toe symptom/complaint

2.9

307.7

4631

10064

M02AA10

ATC

ketoprofen; topical

6.6

307.7

2625

2395

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

6.9

307.7

2122

1792

M01AE11

ATC

tiaprofenic acid; oral, rectal

15.1

307.7

548

197

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.5

307.7

6313

16686

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

8.3

307.7

1662

1146

J01FA09

ATC

clarithromycin; systemic

3.1

307.7

4699

9737

M02AA15

ATC

diclofenac; topical

7.7

307.7

1043

746

M75.1

ICD-10 Finland

Rotator cuff syndrome

7.6

307.7

4407

3826

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

10.1

307.7

1178

649

M01AC06

ATC

meloxicam; systemic, rectal

17.7

307.7

6561

2933

R07.4

ICD-10 Finland

Chest pain, unspecified

2.7

307.7

4218

9707

A07EC01

ATC

sulfasalazine; oral, rectal

11.0

307.7

1748

913

M25.5

ICD-10 Finland

Pain in joint

7.1

307.7

6284

6600

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

9.3

307.7

594

345

N06AX16

ATC

venlafaxine; oral

3.3

307.7

2170

3822

R06AX22

ATC

ebastine; oral

2.7

307.7

2308

4818

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

10.1

307.7

1052

578

M01AH01

ATC

celecoxib; oral

38.0

307.7

4993

936

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

17.2

307.7

545

172

M01AE03

ATC

ketoprofen; systemic, rectal

7.8

307.7

6073

5762

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

9.1

307.7

848

511

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.2

307.7

4576

9111

M79.1

ICD-10 Finland

Myalgia

5.0

307.7

2484

2911

ZXA00

NOMESCO Finland

Right side

2.6

307.7

3990

9403

R51.80

ICD-10 Finland

Headache

4.2

307.7

2597

3637

WX110

NOMESCO Finland

Infiltration anesthesia

2.1

307.7

11808

43814

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

14.1

307.7

862

336

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

8.9

307.7

1244

785

M09AX01

ATC

hyaluronic acid; parenteral

18.6

307.7

886

262

M54.5

ICD-10 Finland

Low back pain

6.5

307.7

7155

8632

A02BC03

ATC

lansoprazole; oral

3.4

307.7

4617

8654

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

9.8

307.7

984

555

M45

ICD-10 Finland

Ankylosing spondylitis

25.9

307.7

508

106

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

2.0

307.7

5776

18173

N02CC07

ATC

frovatriptan; oral

10.6

307.2

492

250

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

25.7

307.1

350

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

7.4

305.8

615

448

OAB91, ,

SPAT

4.6

303.8

957

1146

SFA20

NOMESCO Finland

Two-surface restoration

1.8

303.8

8852

32618

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.6

303.0

2361

5228

WX002

NOMESCO Finland

Sedation and analgesia

2.4

301.6

2793

6728

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

11.1

301.1

471

229

M01AB16

ATC

aceclofenac; oral

19.5

299.6

370

102

M47.82

ICD-10 Finland

Other spondylosis, cervical region

9.1

298.7

525

313

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

298.4

4479

13194

WX290

NOMESCO Finland

Other blockage of nerve

1.8

297.3

7266

25286

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.5

294.7

1328

2116

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

5.8

294.3

725

678

K30

ICD-10 Finland

Functional dyspepsia

3.1

294.2

1556

2760

N06AB10

ATC

escitalopram; oral

2.3

294.1

3170

8168

S01GX01

ATC

cromoglicic acid; ophthalmic

2.4

292.6

2759

6695

G04BD12

ATC

mirabegron; oral

3.1

287.3

1543

2762

J05AB01

ATC

aciclovir; systemic

2.3

285.9

3008

7661

E66.01

ICD-10 Finland

Obesity due to excess calories

3.6

285.6

1225

1883

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

23.0

285.4

335

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

12.5

284.9

419

180

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.9

284.2

1745

3387

G04CA02

ATC

tamsulosin; oral

2.0

283.6

4098

11868

SFA10

NOMESCO Finland

One-surface restoration

1.8

283.5

8521

31465

N02CC06

ATC

eletriptan; oral

12.5

282.9

417

180

OAB93, ,

SPAT

4.6

282.3

884

1052

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

281.9

3679

10241

M54.1

ICD-10 Finland

Radiculopathy

7.9

280.7

541

371

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

4.2

276.6

973

1281

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

274.7

8699

32520

N04BC05

ATC

pramipexole; oral

3.9

274.6

1052

1484

N02CC05

ATC

almotriptan; oral

9.7

274.3

463

258

Z3226

NOMESCO Finland

Physiotherapist

2.3

273.3

2652

6505

M79.0

ICD-10 Finland

Rheumatism, unspecified

12.5

271.8

400

172

D01BA02

ATC

terbinafine; oral

2.1

271.2

3532

9807

D07AD01

ATC

clobetasol; topical

2.5

269.8

2177

4889

WX111

NOMESCO Finland

Local infiltration anesthesia

10.1

266.8

439

234

J20

ICD-10 Finland

Acute bronchitis

3.2

265.3

1380

2417

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

264.2

3256

8834

B01AX06

ATC

[U] rivaroxaban

18.7

259.9

325

SPAT1212

SPAT

Extensive examination of musculoskeletal system

3.6

259.1

1125

1742

M10

ICD-10 Finland

Gout

4.8

258.4

770

874

C05AA08

ATC

fluocortolone; rectal, topical

2.8

257.0

1717

3488

N01

ICPC

Headache

2.7

256.1

1796

3746

K02.1

ICD-10 Finland

Caries of dentine

1.7

255.8

9298

35898

L04AB01

ATC

etanercept; parenteral

29.3

253.6

280

M54.8

ICD-10 Finland

Other dorsalgia

5.5

253.3

661

657

N05AH04

ATC

quetiapine; oral

2.2

253.3

2931

7738

J01DA09

ATC

[U] cefadroxil

2.0

252.7

3776

11012

J01FA15

ATC

telithromycin; oral

3.4

252.5

1176

1912

R51

ICD-10 Finland

Headache

4.4

252.2

820

1008

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

251.1

2695

6891

ZXD20

NOMESCO Finland

Day surgery

2.7

250.3

1719

3543

M19.9

ICD-10 Finland

Arthrosis, unspecified

7.1

250.3

520

395

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

6.8

249.6

536

425

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

249.2

2901

7673

L84

ICPC

Back syndrome without radiat pain

5.0

248.0

702

758

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

12.3

246.7

366

160

M43.1

ICD-10 Finland

Spondylolisthesis

7.9

244.7

471

322

R03BA05

ATC

fluticasone; inhalant

2.2

244.3

2658

6830

SFA30

NOMESCO Finland

Three-surface restoration

1.8

243.4

5658

19097

R06AE09

ATC

levocetirizine; oral

2.5

242.5

1948

4353

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

4.6

241.8

749

881

D11

ICPC

Diarrhoea

2.6

240.7

1819

3940

L11

ICPC

Wrist symptom/complaint

3.1

240.5

1299

2326

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

10.4

239.9

387

199

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

4.2

239.6

825

1065

NH3AA, ,

SPAT

5.1

239.4

669

713

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

3.0

239.0

1359

2511

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.8

239.0

955

1389

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

238.9

10568

42744

KMAK, ,

NOMESCO Finland

1.7

238.0

7705

28598

R07.3

ICD-10 Finland

Other chest pain

3.0

237.4

1376

2572

N05BA01

ATC

diazepam; systemic, rectal

2.6

237.0

1830

4007

M19.8

ICD-10 Finland

Other specified arthrosis

7.3

236.8

483

358

L04AA13

ATC

[U] leflunomide

14.6

234.8

322

118

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

9.2

234.1

407

238

D01

ICPC

Abdominal pain/cramps general

2.6

233.7

1763

3813

S80.0

ICD-10 Finland

Contusion of knee

3.5

233.1

1047

1658

M22.4

ICD-10 Finland

Chondromalacia patellae

8.6

232.9

421

262

SPAT1263

SPAT

Sampling

1.7

232.4

6627

23687

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.4

229.0

1066

1730

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

228.1

2547

6602

N89

ICPC

Migraine

6.3

228.0

519

442

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.8

227.9

1437

2819

WZA00

NOMESCO Finland

Concise certificate

3.6

227.9

954

1436

WZA90

NOMESCO Finland

Other medical or dental certificate

2.0

227.7

3400

9870

M47.9

ICD-10 Finland

Spondylosis, unspecified

8.5

227.6

417

265

H02AB07

ATC

prednisone; oral

2.4

227.2

1976

4582

EMB10

NOMESCO Finland

Tonsillectomy

4.0

226.5

823

1110

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

11.0

224.0

351

171

L89

ICPC

Osteoarthrosis of hip

7.4

223.4

449

326

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

223.0

3984

12301

Z01.2

ICD-10 Finland

Dental examination

1.7

222.8

6629

23907

U07.2

ICD-10 Finland

COVID-19, virus not identified

2.0

222.7

3112

8808

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

5.7

221.7

553

523

J02AC02

ATC

itraconazole; systemic

2.3

221.5

2090

5030

B01AF01

ATC

rivaroxaban; oral

2.6

221.0

1627

3471

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

8.2

219.9

411

269

P06

ICPC

Sleep disturbance

2.6

219.6

1695

3704

K10.3

ICD-10 Finland

Alveolitis of jaws

4.9

218.9

637

706

H02AB04

ATC

methylprednisolone; systemic

2.4

218.4

1993

4722

NG1BG, ,

SPAT

5.7

217.5

542

512

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

14.0

216.9

303

116

R4110, ,

SPAT

3.3

216.3

1059

1777

J35.0

ICD-10 Finland

Chronic tonsillitis

4.2

215.6

749

973

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.8

214.6

4936

16484

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

6.2

213.4

496

433

N02AJ13

ATC

tramadol and paracetamol; systemic

11.7

212.7

323

148

R5140

NOMESCO Finland

Monitoring the use of the aid

2.7

212.4

1441

2941

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.9

212.2

3580

10818

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

9.9

212.0

351

189

L29

ICPC

Musculoskeletal sympt/complt other

3.0

210.1

1150

2072

C10AA07

ATC

rosuvastatin; oral

1.9

209.7

3745

11531

H04.10

ICD-10 Finland

Dry eye syndrome

2.7

208.9

1380

2775

L04AB04

ATC

adalimumab; parenteral

7.8

207.4

400

274

R02

ICPC

Shortness of breath/dyspnoea

2.4

207.2

1878

4430

J01MA12

ATC

levofloxacin; systemic

2.1

207.0

2663

7285

J31.0

ICD-10 Finland

Chronic rhinitis

3.1

207.0

1118

1997

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.5

207.0

1691

3797

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.7

206.0

1371

2767

Z71.8

ICD-10 Finland

Other specified counselling

1.8

205.4

4558

15022

R01AD01

ATC

beclometasone; nasal

2.4

205.2

1896

4512

UJF32

NOMESCO Finland

Coloscopy

1.9

203.5

3527

10738

M75.8

ICD-10 Finland

Other shoulder lesions

5.8

203.5

499

463

NB1AA, ,

SPAT

7.0

202.9

425

326

R06AX13

ATC

loratadine; oral

2.3

202.6

2025

4990

R03BA02

ATC

budesonide; inhalant

2.1

202.4

2462

6585

NG2AA

NOMESCO Finland

Patella X-ray examination

8.8

202.0

360

219

R12

ICD-10 Finland

Heartburn

3.1

201.0

1083

1931

N06AA10

ATC

nortriptyline; systemic

13.4

200.1

285

114

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

199.6

5232

18081

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

199.0

2806

7938

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

13.3

198.0

283

114

ND2AA, ,

SPAT

4.8

197.1

589

669

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

21.6

196.8

235

SPAT1310

SPAT

Counselling related to known health issue

1.7

196.2

4839

16419

NF1AA, ,

SPAT

6.8

196.2

422

335

J01

ICD-10 Finland

Acute sinusitis

4.0

195.1

711

960

N05BA12

ATC

alprazolam; oral

2.8

195.1

1249

2465

M01AG01

ATC

mefenamic acid; oral

14.8

195.1

266

S22.3

ICD-10 Finland

Fracture of rib

3.2

195.0

969

1640

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.4

194.5

903

1460

M75.2

ICD-10 Finland

Bicipital tendinitis

9.9

194.4

323

175

R60.0

ICD-10 Finland

Localized oedema

2.4

194.3

1671

3841

A03CA02

ATC

clidinium and psycholeptics; oral

4.0

193.5

714

974

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

25.0

192.8

221

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

9.8

192.5

321

175

M20.1

ICD-10 Finland

Hallux valgus (acquired)

3.6

191.7

811

1228

N06AB04

ATC

citalopram; systemic

2.0

191.6

2744

7798

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

10.9

190.8

300

147

SPAT1283

SPAT

Restricted health certificate

2.0

188.9

2722

7749

M01AB51

ATC

indometacin, combinations; oral, rectal

14.0

188.7

263

100

M77.9

ICD-10 Finland

Enthesopathy, unspecified

6.2

188.7

434

374

XKD00

NOMESCO Finland

Uroflowmetry

2.0

187.3

2492

6885

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

186.9

2632

7428

SGA01

NOMESCO Finland

Emergency treatment

2.1

185.9

2208

5836

R01AD11

ATC

triamcinolone; nasal

2.9

185.7

1097

2066

M77.0

ICD-10 Finland

Medial epicondylitis

9.7

185.5

311

171

M10.0

ICD-10 Finland

Idiopathic gout

4.7

185.3

566

656

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.7

184.7

1263

2583

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

5.6

184.3

469

453

E66

ICD-10 Finland

Obesity

4.0

182.2

661

889

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

5.1

182.1

502

527

M70.7

ICD-10 Finland

Other bursitis of hip

9.4

181.8

311

177

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

4.1

181.4

649

863

S06.0

ICD-10 Finland

Concussion

2.4

180.3

1622

3802

N40

ICD-10 Finland

Hyperplasia of prostate

1.8

180.3

3506

11031

S83.5

ICD-10 Finland

Sprain and strain involving (anterior)(posterior) cruciate ligament of knee

4.9

180.0

517

565

L14

ICPC

Leg/thigh symptom/complaint

2.9

179.5

1084

2067

R21

ICPC

Throat symptom/complaint

1.9

179.2

3213

9846

M65.3

ICD-10 Finland

Trigger finger

4.9

178.1

512

560

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

4.8

178.1

523

584

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

8.0

177.8

337

225

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

7.2

177.6

365

273

G54.0

ICD-10 Finland

Brachial plexus disorders

8.0

176.9

336

225

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

10.8

176.8

280

139

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

12.0

176.7

264

117

NBG10

NOMESCO Finland

Acromioplastia

9.2

176.5

306

178

SPAT1202

SPAT

Intra-articular injection

6.5

176.5

390

320

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.1

176.3

2049

5362

L20

ICPC

Joint symptom/complaint NOS

4.8

176.2

523

590

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

15.2

176.0

237

NA3AA, ,

SPAT

6.9

175.0

371

289

H01

ICPC

Ear pain/earache

2.3

174.2

1618

3846

S29

ICPC

Skin symptom/complaint other

2.0

174.1

2656

7698

G04BD08

ATC

solifenacin; oral

3.3

173.7

847

1414

G56.2

ICD-10 Finland

Lesion of ulnar nerve

5.7

173.7

429

401

J45

ICD-10 Finland

Asthma

2.5

172.9

1335

2905

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

4.3

172.3

569

707

J01DA06

ATC

[U] cefuroxime

2.2

171.9

1809

4541

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

7.5

171.5

340

242

J05AB11

ATC

valaciclovir; oral

2.2

171.3

1780

4444

K07.60

ICD-10 Finland

Snapping jaw

3.8

171.0

656

922

C07AB07

ATC

bisoprolol; oral

1.6

170.9

6991

26873

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768797) Stomach Pathology biopsy report

2518

5613

2.58

320.06

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8041

28644

1.84

309.25

5.4

8.3

1.21

mmol/l

7.93

6726

24128

(3026361) Erythrocytes [#/volume] in Blood

17034

76221

3.13

307.65

22.7

18.8

4.52

4.51

e12/l

1.39

16646

73042

(3013826) Glucose [Moles/volume] in Serum or Plasma

9644

35087

1.93

307.65

4.3

5.3

6.61

6.85

mmol/l

20.53

9048

31864

(3010813) Leukocytes [#/volume] in Blood

17038

76219

3.14

307.65

22.7

18.8

6.91

6.79

e9/l

6.20

16656

73002

(3019198) Lymphocytes [#/volume] in Blood

9086

30202

2.14

307.65

6.1

6.3

1.95

1.87

e9/l

2.95

8080

26634

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3985

5118

4.95

307.65

1.3

1.2

27.73

36.89

iu/ml

1.10

1222

1547

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12785

43831

2.72

307.65

7.1

7.6

75.76

80.47

u/l

18.82

12053

41116

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16446

69348

3.17

307.65

10.9

8.7

27.27

25.91

u/l

6.93

15932

66319

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

14738

61715

2.24

307.65

4.3

3.8

4.55

4.56

mmol/l

0.66

13728

57300

(3031040) Bacteria [#/volume] in Urine by Automated count

10953

39640

2.11

307.65

4.8

4.0

1264.31

1458.43

e6/l

0.12

149

676

(3022096) Basophils/100 leukocytes in Blood

8149

26911

2.06

307.65

6.3

6.5

0.65

0.63

2.48

7612

25115

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

16148

62078

3.83

307.65

15.8

13.4

22.22

26.99

mg/l

52.44

13496

46675

(3026493) Urate [Moles/volume] in Serum or Plasma

5288

11633

2.95

307.65

2.6

3.1

4236.92

5700.48

umol/l

1.35

4592

10316

(3009542) Hematocrit [Volume Fraction] of Blood

17024

75939

3.16

307.65

22.7

19.0

40.47

40.39

0.14

16188

69298

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7844

27147

1.90

307.65

2.6

2.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6431

20277

2.02

307.65

3.7

73.80

77.21

ng/l

0.04

4131

14577

(3037467) Urinalysis macro (dipstick) panel - Urine

11736

41260

2.35

307.65

4.6

4.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

15899

64112

3.12

307.65

16.8

16.3

3.98

3.96

mmol/l

9.02

15510

61667

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12154

45662

2.16

307.65

4.0

3.5

14.71

14.82

pmol/l

4.74

11106

40860

(3001604) Monocytes [#/volume] in Blood

8829

28969

2.15

307.65

6.1

6.3

0.60

e9/l

0.16

7709

25025

(3000963) Hemoglobin [Mass/volume] in Blood

17037

76274

3.12

307.65

22.8

18.9

136.14

135.10

g/l

14.71

16838

74641

(3019550) Sodium [Moles/volume] in Serum or Plasma

15868

63940

3.10

307.65

16.6

16.2

139.63

139.52

mmol/l

6.52

15502

61628

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

14785

57473

2.74

307.65

13.9

13.0

84.49

82.24

ml/min/173m2

21.12

12600

45036

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

14595

59543

2.36

307.65

4.5

3.9

5.89

mmol/l

0.08

13338

54074

(3018010) Neutrophils/100 leukocytes in Blood

8551

28428

2.08

307.65

6.1

6.3

57.47

58.27

7.42

8035

26651

(3024731) MCV [Entitic volume]

17032

76212

3.12

307.65

22.6

18.7

90.91

90.34

46.50

16831

74558

(3037522) Nuclear Ab [Titer] in Serum

2929

5689

3.03

307.65

1.3

486.57

547.50

titre

0.77

560

1158

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10947

40819

2.00

307.65

3.2

2.7

47.03

45.49

u/l

0.87

10237

38113

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

13992

54397

2.44

307.65

5.6

5.2

39.23

39.67

mmol/mol

6.10

13026

50087

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4099

10064

2.47

307.65

1.7

2.1

1.08

1.69

mg/l

18.04

3048

7694

(3006315) Basophils [#/volume] in Blood

8860

29028

2.16

307.65

6.1

6.4

0.04

e9/l

3.49

7720

25080

(3013115) Eosinophils [#/volume] in Blood

9119

29974

2.18

307.65

6.2

6.9

0.19

e9/l

0.83

8047

26214

(3007461) Platelets [#/volume] in Blood

17020

76058

3.13

307.65

22.7

18.8

250.57

246.73

e9/l

11.11

16687

73117

(3019069) Monocytes/100 leukocytes in Blood

8429

27894

2.08

307.65

6.6

6.8

8.49

8.64

3.89

7898

26100

(3006504) Eosinophils/100 leukocytes in Blood

8392

27767

2.08

307.65

6.3

6.5

2.76

2.75

0.09

7851

25971

(3013707) Erythrocyte sedimentation rate by Westergren method

12906

39286

3.39

307.65

4.7

3.3

11.17

12.99

mm/h

31.91

12096

35815

(40761511) CBC panel - Blood by Automated count

16184

68445

2.90

307.65

14.4

12.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

14650

61136

2.24

307.65

4.2

3.7

1.40

1.44

mmol/l

26.68

13579

56587

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3800

4532

5.29

307.65

1.3

1.2

10.90

12.19

u/ml

0.28

1481

1575

(3009261) Glucose [Presence] in Urine by Test strip

8511

29154

1.99

307.65

3.7

3.4

0.00

estimate

0.09

1751

5450

(3013650) Neutrophils [#/volume] in Blood by Automated count

9905

33666

2.18

307.65

8.1

10.5

4.24

4.26

e9/l

0.43

8682

29315

(40760892) CBC W Ordered Manual Differential panel - Blood

8406

27116

2.15

307.65

6.5

7.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15017

62930

2.34

307.65

4.7

4.1

2.70

2.71

mmol/l

0.38

13894

58091

(3002030) Lymphocytes/100 leukocytes in Blood

8648

29002

2.07

307.65

6.4

6.5

27.95

26.99

11.91

8134

27230

(3008898) HLA-B27 [Presence]

1259

929

7.58

307.65

1.1

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14214

58677

2.17

307.65

3.8

3.4

1.33

1.22

mmol/l

46.12

13063

53987

(3021601) Nitrite [Presence] in Urine by Test strip

8405

28873

1.97

307.65

5.0

4.7

0.00

estimate

0.50

1804

5627

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14356

56595

2.48

307.65

4.8

4.0

2.11

2.28

mu/l

0.43

13240

51597

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8454

28961

1.99

307.65

5.2

6.4

11.19

12.47

umol/l

13.30

7945

27412

(3044889) 12 lead EKG panel

10848

39327

2.09

307.65

3.7

—

(3035350) Ketones [Presence] in Urine by Test strip

8434

28945

1.98

307.65

3.7

3.4

0.00

estimate

1.10

1877

6033

(3035941) MCH [Entitic mass]

17034

76194

3.13

307.65

22.6

18.7

30.30

30.12

31.97

16833

74545

(3015736) pH of Urine

6836

23147

1.88

307.17

3.4

3.2

5.87

5.95

1.04

588

1264

(40768804) Tissue Pathology biopsy report

6324

20938

1.89

303.18

2.1

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2246

4871

2.62

299.88

1.5

1.3

—

(3018095) Leukocytes [#/volume] in Urine

6231

20638

1.89

296.96

3.8

4.0

78.33

132.62

e6/l

5.07

4418

14683

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6760

23010

1.86

296.14

2.2

2.3

75.43

74.40

nmol/l

1.98

6053

20802

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5358

16929

1.94

292.73

2.5

2.7

57.67

64.14

u/l

1.07

4927

15706

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7257

25376

1.83

290.66

4.9

7.4

1.21

mmol/l

11.27

6575

23189

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5053

15771

1.94

284.53

2.1

2.2

179.68

266.77

u/l

6.16

4727

14801

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6734

23315

1.82

274.13

2.1

1.9

95.55

92.82

pmol/l

4.30

3610

12845

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3637

10177

2.10

274.11

1.8

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10894

43572

1.76

271.92

3.5

2.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

640

585

5.93

264.87

1.7

1.5

13280.15

13349.48

e6/l

0.01

446

427

(3022217) INR in Platelet poor plasma by Coagulation assay

7615

27706

1.76

258.68

12.6

21.5

1.21

1.42

inr

68.48

2332

8277

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

711

746

5.18

258.63

1.4

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

5459

17974

1.85

256.95

2.9

3.6

2.35

2.34

mmol/l

1.71

4782

15784

(3002385) Erythrocyte distribution width [Ratio]

13472

58017

1.81

250.80

17.7

16.5

15.19

14.71

0.71

13247

56592

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6005

20493

1.80

250.80

5.1

4.5

2.87

4.93

ug/l

3.83

5360

18158

(3044640) Blood type and Crossmatch panel - Blood

5324

17511

1.84

250.11

2.5

—

(3021788) Differential panel - Synovial fluid

525

417

6.79

244.13

1.6

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7547

27715

1.73

243.89

2.8

3.0

121.41

128.23

ug/l

1.09

6995

25712

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3994

12097

1.94

238.68

1.3

1.42

2.16

u/ml

2.77

1070

3130

(3024561) Albumin [Mass/volume] in Serum or Plasma

6973

25289

1.72

232.26

4.2

5.8

35.87

34.89

g/l

34.43

6463

23447

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6393

22645

1.74

231.02

3.8

3.6

—

(3002582) Erythrocytes [#/volume] in Urine

5324

17867

1.80

230.87

3.3

3.6

58.19

123.08

e6/l

2.90

4138

13870

(36304419) Bacteria [Presence] in Urine

4761

15441

1.84

230.31

3.2

3.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4119

12862

1.88

222.86

2.4

2.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4813

15829

1.81

221.15

4.4

4.0

21.67

22.45

2.51

2236

7960

(3030467) Casts [#/volume] in Urine by Automated count

4850

16028

1.80

219.01

3.2

3.5

0.38

0.49

e6/l

2.62

3754

12342

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3620

10938

1.92

214.97

3.2

2.9

0.75

0.89

ug/l

7.29

2349

7491

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1402

2806

2.76

214.17

2.4

2.3

24.06

21.34

au/ml

0.38

117

201

(3007164) IgA [Mass/volume] in Serum or Plasma

3498

10536

1.92

208.95

1.4

1.5

2.30

2.43

g/l

3.26

2161

6530

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1291

2526

2.82

205.07

1.3

47.32

59.90

au/ml

0.84

115

(3048689) Calprotectin [Mass/mass] in Stool

2448

6535

2.12

202.21

2.3

3.2

125.33

160.58

ug/g

4.29

1947

5277

(3013512) EKG study

4654

15563

1.77

198.74

3.9

4.0

—

(3021589) Normoblasts [#/volume] in Blood

7318

27726

1.64

197.95

10.0

0.00

e9/l

0.54

6023

22751

(3000492) Spirometry study

1884

4580

2.30

193.92

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

3825

12214

1.82

188.69

2.6

3.0

5.12

5.42

e6/l

0.72

3435

10957

(3041096) Erythrocytes [Presence] in Urine by Automated

4777

16377

1.72

184.83

3.3

3.2

—

(3044941) Cell count panel - Synovial fluid

424

404

5.63

168.66

1.5

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

852

1465

3.16

166.91

1.2

1.13

1.27

u/ml

0.08

110

(3023368) Bacteria identified in Blood by Culture

4727

16612

1.67

163.47

4.1

4.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3947

13204

1.73

163.29

1.6

1.5

20.14

19.28

nmol/l

2.82

3404

11592

(3003338) MCHC [Mass/volume]

13132

58763

1.60

162.96

18.9

16.6

332.78

332.72

g/l

0.26

13021

57999

(40758558) Short blood count panel - Blood

4183

14240

1.71

162.51

6.1

7.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4545

15840

1.68

161.89

2.9

3.4

1434.61

2247.63

ng/l

23.58

3739

13899

(3011397) Hemoglobin [Presence] in Urine by Test strip

3864

12902

1.73

160.54

3.6

3.3

—

(3042936) Bacteria identified in Isolate by Culture

2569

7626

1.90

155.67

1.9

2.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4531

15940

1.66

154.56

2.3

2.93

2.98

mg/l

0.61

3830

13594

(3018418) pH of Serum or Plasma

4762

17025

1.64

152.18

3.3

5.3

7.40

1.49

980

3378

(3033658) Prothrombin time (PT) actual/Normal

4116

14177

1.68

151.59

3.8

4.5

89.83

84.51

30.64

4024

13837

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2994

9415

1.80

151.29

2.8

3.2

2.44

2.45

mmol/l

3.07

2602

8118

(1002224) Polysomnography panel

802

1436

3.03

147.07

1.1

1.0

—

(3029937) Albumin [Presence] in Urine by Test strip

4436

15714

1.64

145.91

4.1

3.6

0.00

estimate

0.10

1744

5218

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1663

4349

2.11

141.76

2.3

1.9

12.19

11.91

nmol/l

0.59

1483

3898

(3007853) Bacteria identified in Skin by Aerobe culture

2171

6339

1.91

136.85

1.7

1.8

—

(3019225) pH of Specimen

1741

4731

2.03

134.03

3.7

5.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

328

311

5.63

131.02

1.6

1.5

59.12

63.02

0.67

203

210

(3017732) Neutrophils [#/volume] in Blood

1344

3366

2.19

126.87

2.7

3.5

4.94

5.27

e9/l

0.33

1072

2694

(3026470) Cobalt [Mass/volume] in Blood

157

18.94

126.36

2.0

1.6

3.44

1.94

ug/l

2.04

142

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

819

1620

2.74

126.35

1.6

9.33

2.88

iu/ml

0.41

153

413

(3022145) Colonoscopy Study observation

1907

5484

1.93

124.99

1.3

1.5

—

(3025577) Chromium [Mass/volume] in Blood

154

19.00

124.10

2.1

1.6

2.03

1.65

ug/l

0.55

128

(3001019) Free T4 and TSH panel - Serum or Plasma

952

2076

2.49

121.77

1.6

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2896

9579

1.70

120.30

2.9

3.0

1.00

1.19

e6/l

1.30

1594

5585

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

652

1165

3.02

119.72

1.7

2.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5288

20290

1.52

119.18

2.9

3.2

34.76

34.09

u/l

0.08

5000

19187

(3026008) Bacteria identified in Urine by Culture

4899

18530

1.53

117.61

3.2

2.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2683

8758

1.72

116.51

2.4

2.0

—

(1761868) Lipid panel - Serum or Plasma

5512

21455

1.50

115.28

2.7

—

(3009508) Creatinine [Moles/volume] in Urine

4878

18537

1.52

113.92

3.1

3.5

8.05

7.66

mmol/l

5.86

4059

15861

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2900

9751

1.67

112.66

2.5

2.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1654

4729

1.92

109.52

2.0

2.2

363.94

401.18

nmol/l

10.36

1512

4370

(3026782) Osmolality of Urine

3541

12612

1.59

109.16

2.8

3.3

552.83

545.73

mosm/kgh2o

1.02

3049

10908

(3000494) Fungus identified in Specimen by Culture

1933

5835

1.83

108.54

1.4

1.5

—

(36660697) Celiac disease serology panel - Serum

1497

4159

1.97

107.47

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1932

5863

1.82

106.57

4.2

4.1

31.78

32.80

3.29

1352

4027

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

556

977

3.06

104.80

1.2

1.3

25.51

45.57

u/ml

0.69

(3013139) Helicobacter pylori Ag [Presence] in Stool

1146

2924

2.13

102.76

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1949

6000

1.79

102.40

6.9

7.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2753

9342

1.65

102.32

3.1

2.10

2.58

e6/l

1.91

1456

5364

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3474

12497

1.57

101.77

1.7

32869503.41

29447448.41

pmol/l

0.12

2872

10344

(3002256) Pathology report gross observation

2064

6480

1.76

101.53

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

525

918

3.07

99.72

2.0

1.6

206.76

189.68

pmol/l

1.98

497

871

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3123

11024

1.59

98.74

3.8

3.7

313.49

673.06

ng/l

6.90

2371

8839

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

516

901

3.07

98.22

1.2

1.3

11.74

9.75

u/ml

0.17

136

(4200892) Spirometry reversibility

1162

3037

2.08

97.94

1.4

1.5

—

(3025941) Bacteria identified in Stool by Culture

1152

3003

2.09

97.74

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

727

1551

2.53

96.86

2.0

1.5

38.15

44.81

nmol/l

8.66

710

1525

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

508

887

3.07

96.70

1.2

1.3

7.57

10.45

u/ml

0.16

(3005322) IgE [Units/volume] in Serum or Plasma

1145

2995

2.08

96.26

1.3

215.19

379.70

u/ml

3.92

1054

2756

(3012516) Albumin [Mass/volume] in Urine

4312

16522

1.49

93.41

3.1

3.7

422.20

410.72

mg/l

0.05

2812

11226

(3019309) Folate [Moles/volume] in Red Blood Cells

3154

11318

1.56

92.28

1.8

1.7

1132.86

1162.91

nmol/l

0.98

2329

8545

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2294

7684

1.65

88.55

1.8

1.7

1.44

1.43

0.09

2030

6817

(3020682) Albumin/Creatinine [Ratio] in Urine

4522

17672

1.46

87.75

3.7

4.4

8.38

12.65

mg/mmol

7.36

2878

12049

(40761535) Cells panel - Urine sediment

1390

4029

1.88

87.59

3.5

3.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3791

14359

1.49

85.73

1.6

1.43

1.32

mmol/l

6.64

3188

12274

(3010144) Erythrocytes [#/volume] in Synovial fluid

230

240

5.10

83.91

1.4

57683.86

87756.01

e6/l

0.36

152

161

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1018

2685

2.05

83.49

1.1

1.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2760

9821

1.56

82.81

1.8

1.9

—

(3019150) Specific gravity of Urine by Refractometry

3498

13121

1.50

82.47

4.0

3.5

1.02

kg/l

0.68

516

2322

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1603

4964

1.77

81.64

2.4

2.7

36.40

38.75

u/l

0.29

1367

4294

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

226

242

4.96

80.35

1.5

1.4

30.60

26.93

0.56

134

168

(3023420) DNA double strand Ab [Units/volume] in Serum

298

420

3.78

77.25

1.3

1.6

22.90

35.76

iu/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

359

580

3.30

77.01

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

359

581

3.30

76.81

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

413

743

2.97

74.87

1.2

1.3

36.75

37.60

u/ml

0.03

(3020961) Endomysium IgA Ab [Titer] in Serum

910

2398

2.05

74.66

1.1

269.92

221.11

titre

0.11

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

687

1614

2.29

74.49

1.6

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1804

5971

1.65

71.93

3.5

3.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1474

4639

1.73

70.59

3.8

4.6

0.62

0.76

0.79

450

1586

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

930

2530

1.98

69.96

2.4

2.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

1525

4888

1.70

68.35

4.1

4.8

0.09

0.15

440

1623

(3025159) Blasts/100 leukocytes in Blood

1456

4612

1.72

68.07

4.1

4.8

0.03

0.19

2.60

371

1376

(3045414) Leukocytes [Presence] in Urine

828

2188

2.04

67.34

1.8

1.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1315

4071

1.75

66.51

2.4

2.8

10.42

10.95

g/l

3.78

1187

3741

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1866

6348

1.61

66.50

2.4

2.9

8.29

10.17

umol/l

2.50

1583

5518

(40768443) Skin Pathology biopsy report

790

2065

2.06

66.09

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

1580

5174

1.66

65.30

4.0

4.7

0.83

0.90

0.39

498

1891

(40761536) Microorganisms panel - Urine sediment

1600

5260

1.66

65.15

3.9

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

321

551

3.10

62.81

1.1

1.2

2.42

2.11

iu/ml

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

392

764

2.74

61.91

1.2

7.96

1.24

u/ml

—

(4094501) Cardiovascular stress test using bicycle ergometer

445

932

2.55

61.39

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

385

755

2.72

60.14

1.2

2.33

8.73

u/ml

0.89

(3004616) Nuclear Ab [Presence] in Serum

256

389

3.50

60.04

1.3

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1141

3501

1.76

59.29

2.1

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

586

1429

2.20

58.23

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

587

1438

2.19

57.69

1.2

—

(21494755) Public health laboratory ask at order entry panel

1731

5996

1.57

56.75

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

579

1422

2.18

56.56

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

404

842

2.56

56.28

1.6

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

759

2075

1.97

56.17

1.7

1.9

37.56

38.19

u/l

0.35

680

1804

(3003327) Ova and parasites identified in Stool by Light microscopy

670

1758

2.04

55.42

1.6

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

533

1278

2.23

55.10

1.5

1.4

288.29

258.03

ug/g

2.12

299

760

(3020630) Protein [Mass/volume] in Serum or Plasma

1384

4576

1.64

54.76

2.1

2.4

66.64

65.79

g/l

3.25

1253

4166

(3022948) Iron [Moles/volume] in Serum or Plasma

2682

10300

1.43

53.39

2.1

3.1

13.11

12.65

umol/l

2.32

2478

9605

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

473

1093

2.31

53.18

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

540

1333

2.17

52.10

1.1

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2340

8812

1.46

51.52

1.5

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

492

1176

2.24

51.24

1.4

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1395

4699

1.61

51.14

2.3

6.07

9.66

ug/l

9.33

1146

4078

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

994

3057

1.75

51.09

2.7

2.3

5483.93

8414.62

u/l

1.63

332

1321

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

713

1975

1.94

50.80

3.3

4.8

24.63

24.53

mmol/l

0.37

660

1801

(3039443) Prostate specific Ag panel - Serum or Plasma

365

762

2.55

50.71

1.7

1.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

126

120

5.56

50.31

1.4

6.04

2.81

0.86

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

771

2210

1.87

49.66

1.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1560

5442

1.56

49.29

1.3

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1144

3705

1.67

48.83

3.0

4.1

5.16

5.12

kpa

0.93

1071

3501

(3004716) Salmonella sp identified in Stool by Organism specific culture

1011

3176

1.71

48.22

1.3

1.4

—

(3009343) pH of Capillary blood

1125

3676

1.65

46.37

3.0

4.1

7.41

7.42

0.26

152

571

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

704

2021

1.87

45.12

1.8

—

(3024263) Appearance of Synovial fluid

125

136

4.86

43.90

1.5

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2514

9853

1.40

43.87

2.7

4.0

0.82

mmol/l

0.40

2327

9240

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2470

9655

1.40

43.76

2.1

3.2

2.32

2.28

g/l

3.14

2262

8965

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2259

8696

1.42

43.65

1.5

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

553

1477

2.00

43.61

1.5

1.3

—

(3022313) Gas panel - Capillary blood

801

2428

1.77

43.15

3.2

4.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1085

3577

1.63

43.14

3.0

4.1

1.64

1.70

mmol/l

0.21

801

2569

(3028026) IgM [Mass/volume] in Serum or Plasma

1004

3245

1.66

43.08

1.8

1.9

1.23

1.38

g/l

1.20

908

2959

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1297

4491

1.56

42.10

1.6

1.8

—

(3038026) Centromere Ab [Units/volume] in Serum

168

251

3.55

40.48

1.1

1.2

26.89

33.18

u/ml

0.11

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

632

1822

1.86

39.97

2.1

2.3

2.99

g/l

0.01

569

1628

(3027945) Reticulocytes/100 erythrocytes in Blood

1922

7295

1.43

39.89

2.3

2.9

1.77

1.75

0.25

1659

6448

(3049717) Cytology report of Urine Cyto stain

721

2174

1.78

39.51

2.7

2.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1024

3403

1.62

39.39

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

147

203

3.83

39.33

1.4

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

164

246

3.53

39.32

1.1

1.2

53.33

19.79

u/ml

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1515

5505

1.49

39.31

1.7

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

580

1636

1.89

39.18

2.2

2.4

0.81

0.96

g/l

0.37

503

1395

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2300

9041

1.39

39.07

2.1

3.3

22.86

22.33

0.85

1966

7614

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

550

1525

1.93

39.07

1.6

1.8

1.19

1.13

g/l

3.27

516

1448

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

163

245

3.52

38.97

1.1

1.2

68.60

60.80

u/ml

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

748

2292

1.75

38.82

1.3

1.4

19.61

22.35

iu/l

1.53

641

1915

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

672

1994

1.80

38.81

2.1

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

672

1998

1.80

38.56

2.1

2.2

7.46

7.32

g/l

1.14

606

1805

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

536

1481

1.93

38.46

2.0

2.2

38.17

36.89

g/l

4.30

472

1283

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

670

1994

1.80

38.32

2.1

2.2

3.64

3.73

g/l

0.92

608

1804

(3009214) Lutropin [Units/volume] in Serum or Plasma

657

1944

1.81

38.29

1.4

7.76

8.75

u/l

1.34

551

1573

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1828

6934

1.43

37.97

1.7

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

273

571

2.54

37.89

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

253

509

2.64

37.84

2.0

31.12

30.88

mg/l

0.02

120

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

154

231

3.53

36.95

1.1

1.2

4.67

27.21

u/ml

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

524

1458

1.92

36.86

2.1

2.2

0.05

0.03

g/l

0.26

478

1319

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

485

1314

1.97

36.80

2.1

2.2

0.00

g/l

-0.00

443

1204

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1396

5060

1.49

36.57

3.1

4.7

1.22

mmol/l

0.02

1210

4455

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

628

1862

1.80

36.36

2.1

2.2

10.00

10.67

g/l

2.96

562

1654

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

489

1336

1.95

36.24

2.1

2.2

0.00

g/l

1.18

444

1207

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

175

291

3.19

36.16

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

175

292

3.18

35.98

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

175

292

3.18

35.98

1.2

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

532

1501

1.89

35.92

1.7

1.8

0.23

g/l

0.11

500

1423

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1826

6995

1.42

35.81

1.7

1.8

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

538

1530

1.88

35.48

1.1

2.04

7.78

u/ml

3.76

172

(3015183) Erythrocyte sedimentation rate

132

182

3.84

35.43

1.2

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

5.94

34.89

1.2

38.56

40.93

g/l

0.55

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

466

1269

1.96

34.87

1.3

1.4

485.17

543.36

mg/l

1.18

436

1205

(3022621) pH of Urine by Test strip

1124

3937

1.54

34.51

2.8

2.9

—

(3014051) Protein [Presence] in Urine by Test strip

484

1341

1.92

34.48

2.6

2.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1313

4758

1.49

34.37

2.0

1.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

262

566

2.46

34.13

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

171

291

3.11

34.12

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

170

289

3.12

33.98

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1113

3905

1.53

33.91

1.2

132.36

148.34

iu/ml

0.61

405

1440

(3036071) Salmonella sp Ab [Titer] in Serum

108

131

4.36

33.83

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1579

5955

1.43

33.65

2.1

1.9

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

170

291

3.09

33.62

1.2

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

255

548

2.47

33.58

1.4

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

403

1058

2.03

33.34

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

254

548

2.46

33.19

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

253

547

2.45

32.92

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

255

558

2.43

32.37

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

259

574

2.40

32.02

1.4

1.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

111

145

4.05

31.91

1.9

2.4

8.31

9.54

mg/l

1.07

116

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1206

4361

1.49

31.84

2.5

3.0

69.77

61.60

ml/min/173m2

7.55

461

1822

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1744

6759

1.40

31.81

1.7

1.8

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

760

2471

1.65

31.80

1.6

1.7

14.07

13.37

u/ml

0.05

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

630

1954

1.72

31.35

2.0

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

695

2217

1.68

31.25

1.1

0.91

5.89

u/ml

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

413

1123

1.96

31.07

1.2

1.3

3.69

3.89

mmol/l

2.45

385

1053

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

277

644

2.28

30.87

1.1

10.67

16.13

au/ml

0.49

(3024522) Salmonella sp identified in Specimen by Organism specific culture

252

562

2.38

30.77

1.4

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1871

7400

1.37

30.12

3.5

4.6

230.20

251.09

u/l

9.54

1740

7069

(3045424) Erythrocytes [Presence] in Urine

314

785

2.12

29.51

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

286

689

2.20

29.40

1.0

1.1

1.69

2.81

u/ml

1.47

133

301

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

959

3362

1.53

29.26

3.1

3.6

4.57

4.47

pmol/l

2.20

844

3014

(3011288) Drugs identified in Urine by Screen method

729

2396

1.63

29.24

3.5

2.5

—

(3023520) Reticulocytes [#/volume] in Blood

1413

5354

1.42

29.21

2.4

2.8

69.52

67.51

e9/l

1.09

1012

4040

(3014111) Lactate [Moles/volume] in Serum or Plasma

1439

5486

1.41

28.73

6.0

7.9

1.37

1.41

mmol/l

0.80

1386

5320

(44816559) Phosphatidylethanol [Mass/volume] in Blood

388

1063

1.94

28.61

1.3

—

(3016879) Cocaine [Presence] in Urine

948

3351

1.52

27.84

2.4

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

817

2799

1.56

27.60

2.5

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

1007

3619

1.49

27.33

2.4

1.9

—

(3044290) Cell count panel - Cerebral spinal fluid

382

1063

1.91

26.95

1.3

1.5

—

(3028300) Cannabinoids [Presence] in Urine

1012

3652

1.49

26.92

2.4

1.9

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

124

203

3.23

26.37

1.4

1.5

7.15

7.12

u/l

0.01

106

167

(3027008) Opiates [Presence] in Urine

1007

3646

1.48

26.35

2.4

1.9

—

(3003694) ABO and Rh group [Type] in Blood

4484

20188

1.22

25.89

1.5

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

590

1896

1.66

25.83

1.6

1.7

253.79

315.54

titre

0.24

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

442

1310

1.80

25.70

1.8

2.1

10.60

12.31

mg/l

2.73

403

1221

(3027944) Amphetamines [Presence] in Urine

989

3588

1.48

25.62

2.3

1.9

—

(3026250) Tacrolimus [Mass/volume] in Blood

695

0.08

24.74

33.5

36.3

6.51

7.18

ug/l

1.07

630

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

109

4.07

24.44

1.7

1.9

200.36

111.21

au/ml

0.60

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

280

730

2.03

23.73

1.5

1.8

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

215

505

2.26

23.54

1.3

57.28

54.80

u/ml

0.04

(3038177) Helicobacter pylori Ab [Presence] in Serum

302

813

1.97

23.47

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

184

403

2.42

23.46

1.1

237.45

273.49

mg/l

1.49

157

348

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

161

330

2.58

23.44

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

388

1137

1.81

23.44

1.3

1.6

1266.85

1215.97

e6/l

0.02

308

937

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

388

1137

1.81

23.44

1.3

1.5

15.24

45.92

e6/l

1.97

294

888

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

242

599

2.14

23.41

1.1

0.43

0.39

u/ml

0.06

174

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1024

3808

1.44

23.34

6.0

8.6

24.85

24.47

mmol/l

2.38

1018

3767

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

161

332

2.57

23.17

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

130

239

2.88

23.04

1.1

1.0

5.53

6.39

nmol/l

0.10

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

189

425

2.36

22.81

1.1

36.94

48.40

mg/l

2.95

154

356

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1027

3843

1.43

22.63

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

133

251

2.80

22.54

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

288

775

1.97

22.43

1.1

6.55

4.61

u/ml

0.32

125

424

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

4.58

22.04

1.5

1.4

32.21

36.02

0.26

(3023430) Cat dander IgE Ab [Units/volume] in Serum

272

722

2.00

22.01

1.1

8.90

6.00

u/ml

0.54

103

347

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

527

1718

1.63

21.88

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1383

5490

1.35

21.48

2.1

2.4

0.22

0.21

g/l

6.30

1275

5064

(46235355) HIV 1 and 2 tests - Meaningful Use set

3738

16801

1.21

21.25

1.9

2.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

349

1025

1.81

20.98

1.1

8.05

7.57

u/ml

0.14

179

584

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

174

395

2.33

20.62

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

211

523

2.14

20.41

1.2

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

379

1152

1.75

20.35

1.1

2.04

3.08

u/ml

1.26

190

650

(3013166) Neutrophils/100 leukocytes in Synovial fluid

4.38

20.02

1.2

1.3

56.21

67.61

1.26

(3028707) Methadone [Presence] in Urine by Screen method

461

1488

1.65

19.93

3.2

2.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

332

976

1.81

19.92

1.1

2.98

2.49

u/ml

0.33

149

558

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

237

626

2.01

19.49

1.3

0.18

0.25

nmol/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

112

3.63

19.48

1.1

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

330

976

1.79

19.43

1.1

1.85

1.26

u/ml

0.39

133

478

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

491

1622

1.61

19.38

1.4

1.6

10.16

8.94

iu/ml

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

110

3.65

19.36

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

197

486

2.15

19.31

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

235

622

2.00

19.23

1.3

0.59

1.69

nmol/l

0.85

224

596

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

6.81

19.16

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

474

1557

1.62

19.15

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

106

195

2.87

18.86

1.0

6.85

8.51

iu/ml

0.38

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

194

483

2.13

18.61

1.6

1.3

217.72

194.70

pmol/l

0.20

194

483

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

109

206

2.80

18.52

3.0

2.2

154.37

148.58

umol/l

0.06

(3021387) Prolactin [Units/volume] in Serum or Plasma

750

2748

1.46

18.49

1.5

1.8

290.02

374.66

mu/l

3.60

678

2440

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

999

3858

1.38

18.38

1.4

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

9.89

18.34

1.2

1.1

7.20

6.27

mmol/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

619

2189

1.51

18.18

1.5

1.6

3.65

3.91

mg/l

0.33

474

1353

(3024980) IgG subclass 4 [Mass/volume] in Serum

291

848

1.82

18.01

1.4

1.7

0.68

0.83

g/l

1.57

219

648

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

259

732

1.88

17.62

1.3

1.4

17.28

21.28

u/l

1.35

215

613

(3052851) Hemolysis interference index of Serum or Plasma

517

1771

1.55

17.56

2.7

3.5

—

(4062490) Immunoglobulin typing, IgG

200

517

2.05

17.48

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

349

1084

1.71

17.45

1.3

1.2

257.50

86.00

titre

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2282

9930

1.24

17.38

1.9

2.4

29.87

30.31

2.79

2209

9628

(3010375) cycloSPORINE [Mass/volume] in Blood

684

0.22

17.28

14.3

27.1

106.91

102.16

ug/l

0.14

585

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

148

1604

0.48

17.18

1.1

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

247

696

1.88

16.98

1.5

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

146

336

2.30

16.89

1.6

1.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

198

517

2.03

16.87

1.3

0.37

0.44

g/l

1.58

139

351

(3027135) IgG subclass 1 [Mass/volume] in Serum

198

518

2.02

16.79

1.3

6.27

7.37

g/l

3.48

138

355

(3028192) IgG subclass 2 [Mass/volume] in Serum

198

518

2.02

16.79

1.3

2.98

3.16

g/l

0.66

140

355

(3027801) Oxygen [Partial pressure] in Arterial blood

1708

7228

1.27

16.54

6.2

7.9

12.18

12.38

kpa

0.77

1624

6866

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1708

7231

1.27

16.48

6.2

7.9

5.13

5.03

kpa

3.67

1626

6867

(3048929) Epstein Barr virus Ab [Presence] in Serum

655

2397

1.45

16.28

1.2

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

878

3387

1.38

16.27

2.8

3.1

0.20

0.33

e6/l

4.92

859

3333

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.99

16.08

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.99

16.08

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.99

16.08

1.0

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

144

337

2.26

16.07

2.5

2.2

—

(3037121) Protein [Mass/volume] in Urine

579

2077

1.48

15.92

2.6

3.8

0.25

0.41

g/l

4.44

236

1106

(3022806) Fractional oxyhemoglobin in Capillary blood

270

800

1.79

15.90

1.7

1.9

90.08

89.90

0.19

270

785

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1290

5297

1.30

15.78

2.9

3.4

225.77

300.36

ng/l

5.48

1150

4859

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

209

573

1.93

15.61

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

157

2.89

15.58

1.1

1.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

937

3683

1.36

15.47

8.1

10.6

93.90

93.74

0.31

932

3669

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

127

286

2.35

15.45

1.1

1.10

1.09

u/l

0.01

107

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

850

3291

1.38

15.42

8.3

10.2

24.27

24.12

mmol/l

0.71

819

3151

(3045683) HLA typing for celiac disease panel - Blood or Tissue

123

274

2.37

15.32

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

215

600

1.90

15.26

3.2

4.8

—

(3003396) Base excess in Arterial blood by calculation

1694

7241

1.25

15.03

6.2

7.9

0.89

1.05

mmol/l

0.83

1312

5610

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

943

3728

1.35

15.01

7.9

10.3

1.39

1.36

0.43

937

3699

(3042733) HLA Ab [Presence] in Serum

488

0.15

14.96

4.8

5.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

392

3141

0.65

14.90

1.5

1.7

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

941

3728

1.35

14.77

8.0

10.4

0.65

0.67

1.06

934

3704

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

446

1541

1.54

14.65

1.4

—

(40768800) Prostate Pathology biopsy report

373

1236

1.60

14.65

1.2

—

(4035726) Immunohistochemistry procedure

1163

4773

1.30

14.28

1.3

1.4

—

(3010421) pH of Blood

496

1764

1.49

14.26

3.7

4.8

7.42

0.20

464

1578

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

509

1830

1.48

13.89

2.8

3.1

67.67

52.05

mg/l

0.25

411

1462

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

602

2236

1.43

13.88

2.9

3.2

46.17

84.38

u/ml

2.24

576

2162

(3012501) Base excess in Blood by calculation

443

1548

1.52

13.85

3.8

4.8

2.39

2.67

mmol/l

1.14

280

1019

(3013290) Carbon dioxide [Partial pressure] in Blood

443

1548

1.52

13.85

3.8

4.8

5.03

4.99

kpa

0.50

436

1507

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

277

863

1.70

13.81

1.3

1.7

—

(44813793) Dust mix specific IgE antibody measurement

134

327

2.17

13.64

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

212

613

1.83

13.57

1.6

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.63

13.55

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

390

1332

1.55

13.52

1.3

—

(3027315) Oxygen [Partial pressure] in Blood

443

1558

1.51

13.46

3.8

4.8

8.65

8.60

kpa

0.23

436

1516

(3034860) Kappa light chains.free [Mass/volume] in Serum

507

1834

1.47

13.43

2.8

3.1

160.43

64.20

mg/l

0.41

409

1465

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

389

1332

1.55

13.34

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

813

3203

1.35

13.25

1.7

2.0

1.52

1.44

g/l

1.76

690

2729

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

281

890

1.67

13.21

1.6

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

194

551

1.86

13.14

3.2

3.9

59.18

57.06

0.62

163

449

(3023410) Appearance of Cerebral spinal fluid

179

495

1.91

13.13

1.3

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

190

2.53

13.01

1.3

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

347

2769

0.65

12.97

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

495

1799

1.46

12.83

2.8

3.0

1.61

5.19

ratio

2.03

145

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

158

422

1.98

12.80

1.2

1.83

2.17

mmol/l

4.41

148

389

(3006442) Creatine [Moles/volume] in Serum or Plasma

133

334

2.10

12.66

1.5

1.6

80.63

95.21

umol/l

2.91

133

334

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2012

8917

1.21

12.62

3.8

8.7

1.02

1.06

mmol/l

6.08

1834

8327

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

834

5705

0.76

12.45

1.4

1.6

—

(3016502) Oxygen saturation in Arterial blood

1492

6419

1.24

12.45

6.5

8.4

95.52

95.33

0.49

1438

6166

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

298

2425

0.64

12.25

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

384

1339

1.52

12.18

3.6

4.1

56.68

58.72

2.29

384

1339

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

342

1166

1.55

12.01

1.3

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

192

2.45

11.96

1.1

263.35

404.31

ng/l

0.26

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1093

4566

1.28

11.72

2.8

5.8

84.18

116.76

ng/l

23.51

936

3978

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

132

342

2.04

11.64

1.2

1.4

2.09

1.88

u/ml

0.06

204

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

149

404

1.95

11.62

1.6

2.3

20.28

20.15

nmol/l

0.05

140

389

(40767503) Oxygen content in Capillary blood by calculation

403

1436

1.49

11.57

2.2

2.9

16.52

16.19

0.72

193

822

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

375

1318

1.51

11.50

1.9

4.09

4.19

iu/l

0.06

128

502

(3016244) Insulin [Units/volume] in Serum or Plasma

124

316

2.07

11.43

3.8

2.6

28.59

20.49

mu/l

1.43

112

287

(40768446) Kidney Pathology biopsy report

515

0.27

11.40

1.3

1.9

—

(3007566) Smooth muscle Ab [Titer] in Serum

431

1566

1.46

11.24

1.2

1.3

77.86

90.96

titre

0.41

157

(3010838) Calcium [Moles/time] in 24 hour Urine

243

782

1.64

10.85

2.0

1.8

4.72

4.67

mmol/24h

0.07

210

675

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2947

13666

1.16

10.81

1.6

1.8

—

(3034770) Mitochondria Ab [Titer] in Serum

418

1524

1.45

10.73

1.2

1.3

842.22

922.95

titre

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

209

652

1.70

10.50

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

106

265

2.11

10.30

1.1

1.0

1.12

0.53

u/ml

0.58

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1352

5885

1.23

10.11

6.9

8.9

123.14

120.08

g/l

5.77

1318

5720

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

283

964

1.55

10.06

1.7

1.5

0.29

0.41

nmol/l

1.97

232

810

(3029075) Extractable nuclear Ab panel - Serum

125

2.66

10.02

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

157

2.45

9.95

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

280

955

1.55

9.90

1.2

42.45

41.35

u/l

0.03

244

821

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

126

342

1.95

9.88

3.0

42113.87

41956.43

ug/l

0.03

126

342

(3006462) Nitrate [Presence] in Urine

225

2.18

9.81

4.5

2.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

484

1844

1.39

9.80

1.2

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

216

694

1.65

9.76

1.1

1.51

1.54

g/l

0.42

191

638

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

150

2.46

9.63

1.7

2.2

0.80

0.88

ug/l

0.15

143

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

221

2.17

9.52

1.8

1.7

3.62

12.52

nmol/l

0.41

192

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

108

2.74

9.40

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

192

2.25

9.35

1.1

1.0

11.41

15.16

u/ml

0.30

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

150

440

1.80

9.34

1.9

1.7

—

(4146454) Self-monitoring of blood glucose

168

511

1.74

9.28

2.5

2.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

569

3936

0.75

9.27

1.4

—

(3006270) Folate [Moles/volume] in Blood

165

502

1.74

9.12

1.2

1.1

379.36

348.57

nmol/l

0.95

137

390

(3035933) Granulocytes/100 leukocytes in Blood

120

2.59

9.01

1.4

3.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

172

534

1.70

8.87

1.3

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

315

2374

0.69

8.86

1.3

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

232

2.09

8.82

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.84

8.81

1.7

1.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

194

2.20

8.80

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

569

2266

1.33

8.76

2.0

2.7

310.28

675.38

ug/l

3.53

521

2137

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

135

2.46

8.70

1.1

1.3

135.39

127.97

nmol/l

0.11

(3005033) Fetal Nuchal fold Thickness US

315

2366

0.70

8.70

1.3

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

148

2.39

8.70

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

115

317

1.92

8.69

1.1

1.0

5.95

1.66

u/ml

0.37

106

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1324

5840

1.21

8.69

3.5

4.3

20.52

25.22

ug/l

0.27

1059

4806

(3024471) HLA-A [Type]

397

0.29

8.52

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

240

820

1.55

8.50

1.3

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

282

999

1.49

8.46

1.6

1.4

113.65

119.97

pmol/l

0.06

274

963

(3043238) Trisomy 21 risk [Likelihood] in Fetus

324

2409

0.70

8.46

1.4

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

208

2.13

8.44

1.1

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

255

891

1.51

8.18

1.1

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.35

8.17

1.4

1.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

292

1050

1.47

8.16

3.2

3.6

1.38

1.59

0.42

255

915

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

579

2339

1.31

8.10

1.3

193.90

236.31

miu/ml

2.03

267

1038

(40760888) Immunoglobulin light chains.free panel - Serum

373

1410

1.40

7.99

2.8

3.1

—

(3042517) Benzodiazepines panel - Urine

3.22

7.92

3.8

2.2

—

(3044927) Protein electrophoresis panel - Urine

163

516

1.67

7.89

1.1

1.2

—

(3024932) HLA-DR beta [Type]

387

0.31

7.83

1.3

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

166

2.22

7.83

1.1

1.2

0.29

0.30

g/l

0.86

135

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

117

337

1.83

7.80

1.2

—

(3000991) Gas panel - Venous blood

1241

5499

1.20

7.77

7.2

9.9

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

519

0.40

7.77

2.1

2.6

108.66

154.41

nmol/l

4.70

447

(3014599) Egg white IgE Ab [Units/volume] in Serum

107

300

1.88

7.75

1.1

1.0

2.65

3.15

u/ml

0.08

(3019420) Tryptase [Mass/volume] in Serum or Plasma

241

1.99

7.74

1.5

1.7

6.84

9.29

ug/l

0.63

225

(3020191) Ethanol [Moles/volume] in Serum or Plasma

161

511

1.66

7.73

1.7

1.4

1.54

1.11

promille

2.83

123

398

(3006653) Thiamine [Moles/volume] in Blood

242

1.98

7.66

1.3

1.2

134.63

133.52

nmol/l

0.08

242

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

101

279

1.91

7.64

1.2

1.4

85.73

61.41

1.96

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

151

2.27

7.63

1.2

107.25

115.81

1.46

135

(3037756) Immunofixation for Serum or Plasma

328

1223

1.42

7.61

1.5

1.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.64

7.47

1.0

1.2

229.82

55.30

mg/l

0.53

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

142

440

1.70

7.46

4.4

4.8

87.84

100.23

u/ml

0.08

140

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

264

1.92

7.38

1.2

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

264

1.92

7.38

1.2

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

134

410

1.73

7.36

1.1

297.04

293.65

mg/l

0.14

120

370

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

261

1.92

7.32

2.8

2.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

108

2.49

7.28

1.3

1.5

9.23

10.13

ug/l

0.52

108

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

121

361

1.77

7.25

1.3

1.2

5.69

5.86

umol/l

0.16

110

338

(3002619) Bacteria identified in Specimen by Culture

2.61

7.18

1.1

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

125

1091

0.60

7.18

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.90

7.16

1.1

1.0

—

(3023419) Bacteria identified in Sputum by Culture

239

850

1.49

7.12

2.7

2.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

410

1608

1.35

7.07

2.5

3.3

8.06

8.17

kpa

0.70

402

1572

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

134

1145

0.61

7.05

2.4

2.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

123

2.36

7.04

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.97

7.02

1.1

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

3.51

7.01

1.1

73.96

94.09

ug/l

1.48

(3015235) Bicarbonate [Moles/volume] in Capillary blood

454

1813

1.33

6.95

2.5

3.3

25.01

24.43

mmol/l

2.05

445

1770

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

124

2.34

6.92

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.14

6.75

1.1

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.61

6.74

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.26

6.65

1.4

1.0

—

(3020650) Glucose [Presence] in Urine

130

2.27

6.63

1.7

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

120

2.33

6.63

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

503

2054

1.30

6.59

2.6

2.8

—

(40768793) Breast Pathology biopsy report

243

883

1.45

6.54

1.3

—

(3042631) Mycobacterium sp identified in Specimen

229

824

1.47

6.48

3.0

2.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

284

1065

1.41

6.46

1.5

1.8

—

(3011985) Renin [Units/volume] in Plasma

206

726

1.50

6.46

1.5

1.6

74.21

52.18

mu/l

0.60

178

651

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

6.89

6.39

1.1

4.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

247

1826

0.71

6.35

2.9

7.5

792.00

754.12

iu/ml

0.04

328

(1616796) Gas panel - Central venous blood

417

1670

1.32

6.30

3.3

4.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

317

1.75

6.12

1.1

—

(3051339) Copper [Moles/volume] in Blood

4.71

6.01

1.3

1.2

15.75

16.82

umol/l

0.37

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

165

564

1.55

5.98

3.7

4.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

133

2.18

5.98

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

221

804

1.45

5.96

2.9

2.2

13.21

13.07

1.26

221

788

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

419

1694

1.31

5.95

1.2

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

191

675

1.49

5.95

1.4

839.13

373.93

pmol/l

0.42

169

585

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.92

5.94

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

159

540

1.55

5.93

1.1

—

(3028433) Virus identified in Specimen by Culture

184

1.98

5.87

1.2

—

(3020891) Body temperature

551

2313

1.26

5.85

3.9

5.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.42

5.83

1.2

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

245

915

1.42

5.76

1.6

1.9

9173.33

2648.70

titre

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

115

364

1.67

5.70

1.3

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.43

5.65

3.4

2.3

7.82

7.79

mmol/l

0.01

(3006184) Hemoglobin [Mass/volume] in Capillary blood

394

1595

1.31

5.57

2.0

2.5

131.46

128.18

g/l

1.46

271

1273

(3019060) Gas panel - Arterial blood

932

4157

1.19

5.51

3.7

5.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

359

1437

1.32

5.51

1.5

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

755

3303

1.21

5.49

2.9

5.8

24.23

23.84

mmol/l

2.75

739

3200

(3035947) Staphylolysin Ab [Units/volume] in Serum

300

1.72

5.49

1.1

1.2

4.60

5.83

iu/ml

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

116

373

1.64

5.44

1.3

1.5

—

(3020491) Glucose [Moles/volume] in Blood

131

435

1.59

5.41

1.7

6.38

6.66

mmol/l

0.48

321

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

132

2.12

5.40

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

172

612

1.48

5.24

1.4

1.5

279.61

283.93

mosm/kgh2o

1.59

130

485

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

127

2.12

5.22

1.3

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

156

1.99

5.18

1.1

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

171

1.94

5.15

2.3

3.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

123

408

1.59

5.13

2.3

2.8

522.42

496.61

e6/l

0.22

106

337

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

247

945

1.38

5.11

1.4

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

105

335

1.65

5.10

1.2

1.54

1.52

g/l

0.15

105

335

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

104

331

1.66

5.10

1.5

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

421

0.47

5.04

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

273

1064

1.36

5.04

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

129

435

1.57

5.03

1.2

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.73

5.01

1.1

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

600

2592

1.23

4.98

1.3

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

119

395

1.59

4.97

2.3

2.8

0.21

0.24

e9/l

0.53

105

334

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

229

870

1.39

4.95

5.8

7.0

11.23

11.68

mg/l

0.88

210

800

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

171

616

1.47

4.93

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

311

1.66

4.88

3.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

430

0.49

4.88

1.1

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

491

2082

1.25

4.85

3.0

4.6

1.36

1.47

mmol/l

1.46

485

2029

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

114

378

1.59

4.79

1.7

34.89

29.47

u/ml

0.39

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

165

594

1.47

4.79

1.5

1.8

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

281

1.69

4.77

2.3

2.7

181.08

98.25

au/ml

0.59

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.40

4.75

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

177

1.88

4.70

1.1

1.0

9.42

14.96

u/ml

0.89

102

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

323

1.63

4.68

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.28

4.63

1.1

0.73

0.63

umol/24h

0.77

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

321

1.63

4.57

2.8

3.3

6.87

8.64

mg/l

2.06

257

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.42

4.57

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

618

2704

1.21

4.56

1.8

2.0

1.62

2.29

ug/l

1.08

527

2409

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.74

4.55

1.4

1.6

39.54

46.24

umol/l

0.81

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

277

1.68

4.54

1.3

1.7

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.34

4.52

1.6

1.8

0.29

0.49

ug/l

1.86

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

193

1396

0.73

4.47

1.7

3.6

4045.62

9184.63

u/ml

0.31

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

158

1.90

4.45

1.2

12.78

19.04

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

150

542

1.46

4.32

1.5

1.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

257

1019

1.33

4.31

1.4

1.6

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

202

1.78

4.31

1.3

1.5

14.38

15.14

pmol/l

0.64

173

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

120

414

1.53

4.30

1.6

1.9

4.08

4.98

mg/l

1.10

112

393

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

294

1.63

4.29

1.9

2.1

42.84

142.19

ug/min

2.07

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

183

688

1.40

4.27

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

358

1487

1.27

4.27

1.5

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

366

1525

1.27

4.25

1.5

1.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

223

1.73

4.22

2.0

2.1

1.97

1.87

umol/l

0.52

211

(3001556) Androgen free Index in Serum or Plasma

2.32

4.22

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

212

819

1.37

4.21

1.4

1.5

—

(3012544) pH of Venous blood

1435

6750

1.13

4.21

3.0

5.0

7.37

7.39

0.25

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

103

346

1.57

4.16

1.5

1.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

264

1.66

4.16

1.7

1.6

20.41

22.97

umol/l

0.35

250

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

147

534

1.45

4.14

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

221

1.72

4.11

1.1

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

306

1.60

4.10

1.1

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.89

4.03

1.0

1.6

—

(3011412) CD3 cells [#/volume] in Blood

160

595

1.42

3.99

2.4

2.5

1.29

1.06

e9/l

2.65

143

532

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.39

3.96

1.0

0.49

0.18

u/ml

0.40

(3021901) Oxygen saturation in Capillary blood

329

1367

1.27

3.94

2.4

3.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

103

351

1.55

3.94

1.8

2.85

3.32

u/field

0.17

258

(3002032) Base excess in Venous blood by calculation

1389

6549

1.13

3.94

3.0

5.0

1.92

1.69

mmol/l

1.52

1150

5464

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

141

514

1.45

3.92

1.5

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

621

2761

1.19

3.92

2.0

1.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

120

424

1.49

3.90

2.1

2.9

841.79

570.94

e6/l

2.50

115

412

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.12

3.89

1.1

1.43

3.58

u/ml

0.58

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

102

348

1.55

3.89

1.5

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

274

1117

1.30

3.82

1.9

5.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

316

1.57

3.82

1.4

1.3

112.86

614.71

titre

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1393

6586

1.12

3.78

3.0

5.0

5.86

5.81

kpa

1.12

1345

6365

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

109

842

0.68

3.77

1.4

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

113

398

1.50

3.74

1.2

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

134

489

1.45

3.73

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

469

2967

0.83

3.72

1.3

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

273

1117

1.29

3.72

1.4

1.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

101

2.04

3.72

1.1

1.2

250.04

488.51

pmol/l

0.80

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.49

3.71

1.0

0.01

0.22

u/ml

1.11

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

220

874

1.33

3.70

1.4

1.6

—

(3047189) Immunofixation for 24 hour Urine

237

1.65

3.66

1.9

1.6

—

(3000330) Specific gravity of Urine by Test strip

767

3492

1.16

3.66

3.5

3.6

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

102

2.02

3.63

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

102

2.02

3.63

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

102

2.02

3.63

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

102

2.02

3.63

1.2

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

303

0.49

3.59

1.3

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

155

1.80

3.59

1.8

2.1

11.82

17.80

umol/l

4.54

155

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

142

530

1.41

3.52

1.4

1.3

1.55

1.36

nmol/l

1.10

125

483

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

122

1.90

3.51

1.1

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.18

3.50

1.2

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

1137

5338

1.13

3.49

2.6

3.9

4.53

4.70

kpa

1.77

1091

5131

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.63

3.49

1.1

1.72

1.62

umol/24h

0.22

(3036180) Methadone [Presence] in Urine

120

435

1.46

3.48

2.3

2.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.03

3.46

1.0

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

169

1.75

3.44

2.1

2.0

—

(3004775) Volume in Urine collected for unspecified duration

745

0.68

3.44

1.8

2.6

592.26

675.22

1.18

534

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

444

2800

0.83

3.44

1.3

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

250

1.60

3.42

1.2

1.1

163.62

153.54

mmol/24h

0.45

250

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

234

1.62

3.40

1.3

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

445

2802

0.83

3.39

1.3

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.24

3.37

2.4

2.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

442

2782

0.83

3.36

1.3

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

776

3561

1.15

3.36

8.2

10.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

273

1134

1.27

3.35

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

221

893

1.31

3.35

1.4

1.7

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

3.33

0.0

2.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

207

1.66

3.32

2.8

2.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

444

2790

0.83

3.32

1.3

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

405

1.46

3.31

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

286

1.55

3.29

6.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

579

0.64

3.27

1.7

1.4

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.47

3.25

1.0

0.37

0.46

u/ml

0.08

(3014271) Vancomycin [Susceptibility]

304

1.53

3.24

3.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

296

1.53

3.22

4.7

8.0

43.38

9727.51

u/ml

0.72

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.34

3.20

1.0

0.45

0.14

u/ml

0.31

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

170

1.71

3.15

1.1

1.0

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.80

3.15

1.6

1.5

1.60

3.89

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.80

3.15

1.6

1.5

3.56

2.89

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.80

3.15

1.6

1.5

0.83

0.91

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.80

3.15

1.6

1.5

2.00

4.27

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.80

3.15

1.6

1.5

0.25

3.19

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.80

3.15

1.6

1.5

1.66

3.41

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.80

3.15

1.6

1.5

4.00

3.92

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.80

3.15

1.6

1.5

1.88

2.95

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.80

3.15

1.6

1.5

1.53

3.31

mg/l

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

3.14

0.0

2.1

—

(3036603) Volume of Urine

109

397

1.45

3.13

1.6

1947.51

2004.23

0.23

104

381

(3010503) CD19 cells [#/volume] in Blood

102

367

1.47

3.12

2.5

2.7

0.17

0.43

e9/l

0.65

358

(3028679) Herpes simplex virus Ab [Presence] in Serum

105

380

1.46

3.12

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

307

1.51

3.12

1.4

1.3

46.00

121.25

titre

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.03

3.09

1.4

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

337

1450

1.23

3.07

3.5

2.7

25.48

31.55

mg/l

2.00

202

981

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

279

1.53

3.05

1.2

24.87

8.94

u/ml

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

180

1.67

3.04

1.0

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

6.02

3.03

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.09

3.02

1.2

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

7.37

3.00

1.3

1.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.71

3.00

1.6

1.5

0.75

4.10

mg/l

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

385

0.59

2.99

1.9

2.8

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.11

2.97

1.0

0.30

0.04

u/ml

0.44

(3003181) Sodium [Moles/volume] in Urine

258

1082

1.26

2.97

1.3

1.4

64.82

61.50

mmol/l

0.60

213

851

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

206

1.61

2.95

1.1

94.03

80.27

1.80

113

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

188

0.42

2.93

5.9

10.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1372

6580

1.11

2.92

4.2

10.9

9.93

11.01

mmol/l

5.74

1296

6276

(3043410) Blood group antigens tested for on Red Blood Cells

167

1.67

2.87

1.4

1.6

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.35

2.85

1.0

0.04

2.78

u/ml

0.58

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.11

2.85

1.5

350.92

361.45

umol/24h

0.06

(40761995) Spermatozoa Progressive [#/volume] in Semen

359

0.59

2.82

3.0

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

359

0.59

2.82

6.0

5.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

188

765

1.30

2.78

1.4

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

150

591

1.34

2.77

1.9

1.8

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

218

1.57

2.77

1.1

1.2

104.70

100.41

0.37

206

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

210

1.58

2.76

1.1

95.86

82.27

2.82

113

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

110

1.82

2.74

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

6.14

2.73

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

1.76

2.71

1.1

—

(4034850) Laboratory test

432

1930

1.18

2.70

11.9

9.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.34

2.70

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

166

0.41

2.68

6.2

11.0

—

(3000012) Reticulocyte production index

242

1022

1.25

2.67

2.1

2.2

—

(3030313) Adrenal Ab [Titer] in Serum

2.26

2.63

1.0

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.16

2.62

1.0

0.06

1.15

u/ml

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

112

1.79

2.60

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.11

2.58

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.19

2.58

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

265

1136

1.23

2.57

1.7

2.3

6.11

6.66

umol/l

0.24

183

860

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.55

2.56

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

125

486

1.36

2.55

2.4

2.0

72.55

72.50

0.01

119

468

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.63

2.54

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

321

1406

1.21

2.52

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

141

1.68

2.52

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

143

569

1.33

2.51

1.9

2.0

1.98

2.06

u/field

0.05

214

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

118

456

1.36

2.51

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

118

456

1.36

2.51

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

118

456

1.36

2.51

1.5

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

216

909

1.25

2.48

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

856

4042

1.12

2.48

5.2

7.6

24.47

24.36

mmol/l

0.36

813

3842

(3000093) Morphology [Interpretation] in Blood Narrative

162

658

1.30

2.47

1.1

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.09

2.43

2.1

1.9

—

(40759632) Porphyrins [Mass/mass] in Stool

6.32

2.43

1.2

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

2.37

0.0

3.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.74

2.36

1.4

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

272

1182

1.21

2.35

3.1

3.4

530.28

1114.26

u/ml

0.46

255

1063

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

147

595

1.30

2.32

2.2

3.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.79

2.31

1.2

1.3

24.00

256.00

titre

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.61

2.29

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.86

2.29

2.4

1.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

379

1.38

2.26

1.1

1.2

1.05

1.08

ratio

0.74

136

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.27

2.20

1.0

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

280

1.43

2.17

1.6

2.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.39

2.15

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

2.39

2.15

1.0

1.1

0.22

0.31

u/ml

—

(3045142) Bone marrow Pathology biopsy report

159

658

1.27

2.15

1.2

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.05

2.15

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.24

2.13

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

112

1.69

2.12

1.1

1.0

2.12

0.70

u/ml

0.63

100

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.10

2.10

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.51

2.06

1.1

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.01

2.06

1.1

—

(40765096) Chromosome analysis panel by Banding

143

1.58

1.99

1.1

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

281

1.41

1.98

1.6

2.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

275

1219

1.19

1.98

1.8

2.2

3.57

9.26

titre

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

138

0.46

1.97

1.2

2.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

149

620

1.27

1.96

1.1

1.2

63.21

68.03

u/l

0.30

136

571

(40768795) Lymph node Pathology biopsy report

123

500

1.30

1.94

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

1.80

1.90

1.2

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

5.27

1.89

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

5.27

1.89

2.0

2.4

—

(3025130) Human papilloma virus identified in Specimen

175

746

1.24

1.88

1.7

1.8

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.30

1.88

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

205

1.47

1.88

1.1

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

201

1.47

1.87

2.5

2.9

26.84

29.30

umol/l

0.72

145

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

206

1.46

1.84

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

169

0.53

1.84

6.6

5.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

111

449

1.30

1.84

1.0

1.1

—

(3016750) Collection duration of Urine

536

0.74

1.83

1.6

2.6

470.42

503.61

min

1.27

438

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.35

1.78

1.3

2.6

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.35

1.78

1.4

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.35

1.78

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.81

1.78

2.4

2.7

—

(3016038) Potassium [Moles/volume] in Urine

102

410

1.31

1.77

1.2

39.64

34.15

mmol/l

1.30

362

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

106

1.64

1.77

1.3

1.0

—

(3001729) Color of Synovial fluid

2.23

1.77

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

169

1.50

1.77

1.1

5.34

61.58

u/ml

0.47

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.70

1.76

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.92

1.75

1.3

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

123

508

1.28

1.75

1.2

1.4

—

titre

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

222

1.42

1.74

1.7

2.1

—

(3004451) EKG impression Narrative

317

1.35

1.70

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.88

1.68

1.4

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

108

1.61

1.67

1.4

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

468

2193

1.13

1.66

3.2

3.4

647.39

1240.89

u/ml

0.57

401

1890

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

198

1.44

1.65

1.3

1.2

999.69

40.77

ug/l

0.79

(40757494) Bilirubin.total [Moles/volume] in Blood

287

1.36

1.65

1.7

2.1

11.88

24.88

umol/l

1.18

(3024928) Oxygen saturation in Venous blood

311

1418

1.16

1.65

2.1

4.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.07

1.65

1.4

1.2

4.43

3.00

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

134

874

0.81

1.65

1.4

1.7

7.94

7.42

mmol/l

2.06

129

827

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.69

1.64

1.5

1.6

91.13

108.26

ug/l

0.42

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

113

0.47

1.61

7.4

7.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

1.60

0.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

1.60

0.0

4.5

—

(37021550) Renin [Units/volume] in Plasma --upright

101

1.62

1.60

1.4

77.42

101.13

mu/l

0.28

(3044007) Cell count panel - Peritoneal fluid

201

0.60

1.60

2.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

358

1.31

1.58

1.1

1.2

74.98

99.98

u/l

1.88

328

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

119

0.49

1.57

2.1

2.7

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

148

1.50

1.57

2.3

1.2

97.12

107.28

1.09

141

(3047181) Lactate [Moles/volume] in Blood

448

2102

1.13

1.57

4.5

6.4

1.31

1.33

mmol/l

0.15

391

1878

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

110

457

1.27

1.54

2.5

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

219

1.40

1.54

1.7

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

219

1.40

1.54

1.7

2.1

—

(21494434) Karyotype in Bone marrow

125

528

1.25

1.52

1.2

—

(40768441) Liver Pathology biopsy report

104

430

1.27

1.51

1.2

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

120

1.54

1.49

1.1

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

170

0.59

1.47

1.3

1.4

23.57

27.29

g/l

0.40

143

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

223

1002

1.17

1.46

1.3

4.88

4.10

u/ml

0.29

490

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

102

424

1.27

1.44

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

388

0.73

1.43

1.7

8.6

4010.68

1007.73

mg/l

0.34

294

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.07

1.42

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.07

1.42

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.66

1.40

3.3

2.6

0.50

0.43

u/field

0.13

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.79

1.40

1.2

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

206

0.64

1.39

3.1

5.7

65.20

70.89

0.42

169

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

188

1.40

1.38

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

251

1.34

1.38

2.5

1.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.93

1.37

1.4

1.1

17.40

7.10

u/l

1.06

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

348

1.29

1.37

1.1

1.2

16.87

25.34

u/l

1.84

317

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.11

1.36

1.3

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.29

1.36

1.0

3.0

1.61

1.87

mu/l

—

(3041184) Isoniazid [Presence] in Urine

3.29

1.36

2.2

2.6

—

(4212803) Bone marrow aspirate examination

1.87

1.36

1.1

—

(3033799) Differential panel - Peritoneal fluid

217

0.65

1.35

1.6

2.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

103

433

1.25

1.34

1.9

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.68

1.34

1.2

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

260

0.69

1.32

2.4

2.1

538.72

2960.93

e6/l

0.55

184

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

235

0.67

1.32

2.4

1.9

9221.50

13378.16

e6/l

0.26

129

(3044242) Glucose [Moles/volume] in Arterial blood

313

1.30

1.31

1.6

2.0

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.15

1.31

1.1

1.2

0.18

1.98

umol/24h

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

227

1033

1.16

1.30

1.4

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

227

1033

1.16

1.30

1.4

1.8

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

100

422

1.25

1.28

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

2.34

1.26

1.3

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

143

1.44

1.25

1.3

1.2

83.50

76.13

0.17

(3027456) Digoxin [Moles/volume] in Serum or Plasma

259

1551

0.88

1.24

2.9

3.1

0.83

0.80

nmol/l

0.37

192

1190

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

155

688

1.19

1.22

2.5

2.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.72

1.21

2.1

2.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

328

0.74

1.21

2.6

3.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

593

0.81

1.19

1.1

1.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

610

0.81

1.19

9.5

13.5

0.57

0.65

mmol/l

3.55

569

(3026692) Albumin [Mass/volume] in Peritoneal fluid

204

0.67

1.18

1.7

1.4

14.43

14.53

g/l

0.02

167

(3000060) B lymphocytes [#/volume] in Blood

163

1.39

1.17

2.3

2.2

143.18

583.64

e6/l

0.46

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

134

590

1.20

1.17

1.3

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

268

1.30

1.17

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

173

1.37

1.14

1.1

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

142

1.41

1.13

1.3

1.2

85.54

82.63

0.07

(3048879) Bone marrow aspiration report

142

1.41

1.13

1.7

2.0

—

(3008607) Semen analysis panel

1.60

1.11

1.2

—

(3011648) Oxygen content in Venous blood

118

518

1.20

1.08

1.6

2.8

10.94

11.09

0.12

118

518

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.57

1.07

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

366

1.24

1.07

1.5

1.6

6.74

7.66

u/l

0.23

291

(1761482) Bacteria [#/volume] in Urine by Culture

359

2086

0.90

1.07

4.8

3.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

224

1037

1.14

1.07

1.3

4.23

4.59

u/ml

0.08

379

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

263

1.28

1.06

1.0

1.1

90.40

94.10

0.44

219

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.61

1.04

1.1

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.97

1.03

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.86

1.03

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.69

1.02

1.1

6.83

13.59

iu/ml

—

(3050794) Legionella sp Ab [Presence] in Serum

1.76

1.02

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.05

0.98

1.6

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

375

1.22

0.98

1.3

1.4

5.61

5.38

mmol/l

1.30

358

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.43

0.97

1.2

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

1.63

0.97

1.1

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

295

1.25

0.97

1.9

2.5

47.50

52.58

umol/l

0.87

255

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.71

0.95

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

859

4265

1.06

0.95

2.7

4.0

131.42

126.84

g/l

7.11

831

4176

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.58

0.94

1.2

—

(3016135) IgD [Mass/volume] in Serum

2.26

0.93

1.2

1.1

27.05

130.16

mg/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

298

1.24

0.90

1.0

272.38

334.01

ng/l

1.32

211

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

161

0.69

0.90

3.0

2.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

199

928

1.13

0.89

1.1

1.2

117.98

109.93

2.93

182

860

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.76

0.89

1.0

1.1

9.55

11.98

u/ml

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

309

1.23

0.87

1.3

1.5

70.99

73.04

0.55

291

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.49

0.87

1.2

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.57

0.86

1.3

1.2

128.50

109.58

ug/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.50

0.86

1.4

1.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.83

0.85

1.5

1.3

387.25

457.30

nmol/l

—

(3022689) Creatine [Moles/volume] in Urine

169

1.31

0.85

1.6

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

234

1107

1.11

0.84

1.1

139.83

912.64

iu/ml

0.50

235

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.83

0.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

200

939

1.12

0.82

1.1

—

(3036489) Thrombin time

519

2549

1.07

0.82

2.0

2.5

21.08

21.58

1.21

452

2278

(3023183) Ammonium ion [Moles/volume] in Plasma

305

1465

1.10

0.82

2.3

2.6

34.77

31.90

umol/l

0.46

275

1319

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.71

0.82

1.0

1.3

1.00

u/field

—

(40757373) Influenza virus identified in Isolate

194

0.73

0.82

1.2

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

342

1654

1.09

0.80

1.1

1.3

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

303

1.22

0.80

1.3

1.5

405.56

768.90

mu/l

1.99

285

(3029612) Listeria sp Ab [Titer] in Serum

2.39

0.80

1.4

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

294

1.22

0.79

1.1

1.2

31.38

28.10

u/l

0.10

263

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.46

0.78

1.0

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.43

0.78

1.3

1.2

16.27

20.53

u/l

0.56

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

295

1.21

0.77

1.1

1.2

89.53

91.35

u/l

0.04

265

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

117

1.35

0.76

2.2

76.29

86.98

ng/l

0.19

(3009871) Measles virus Ab [Titer] in Serum

210

1.25

0.76

1.7

1.5

—

(3007463) Buprenorphine [Presence] in Urine

1.84

0.74

11.3

3.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

108

491

1.16

0.74

1.4

1.9

—

(3012565) Volume of 24 hour Urine

321

1.20

0.73

2.8

2.4

2177.34

1772.20

1.65

283

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

302

1.20

0.73

1.0

755.27

702.24

ng/l

0.40

205

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

302

1.20

0.73

1.0

39.19

44.49

ng/l

0.61

211

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.03

0.72

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.03

0.72

1.0

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

226

1.24

0.72

1.4

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

144

670

1.13

0.72

2.7

3.6

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.76

0.71

1.1

1.0

8.12

8.55

mmol/l

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.76

0.71

1.3

1.0

209.11

213.71

nmol/l

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

278

1594

0.92

0.71

1.2

1.7

116.65

112.57

u/ml

0.34

357

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.37

0.70

1.9

2.8

40.96

42.18

umol/l

0.08

(3014148) Varicella zoster virus Ab [Titer] in Serum

196

1141

0.90

0.69

1.2

—

(3017569) Oxygen content in Arterial blood

304

1.20

0.69

1.9

2.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

113

519

1.15

0.69

1.2

1.3

38.00

190.87

titre

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

138

1.30

0.68

1.2

1.6

2716.79

88.07

ng/l

0.47

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.47

0.68

1.6

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

381

2152

0.93

0.68

2.5

4.4

1.39

1.70

mg/l

11.88

340

1991

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

113

520

1.14

0.67

1.2

1.3

144.74

195.57

titre

0.30

(3008116) Ketones [Moles/volume] in Urine by Test strip

143

1.29

0.67

1.7

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.38

0.67

1.1

1.4

0.27

0.19

nmol/l

0.34

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

102

467

1.15

0.66

1.1

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.64

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.38

0.63

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.38

0.63

3.4

2.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.62

0.62

7.4

10.5

—

(3038515) Glucose [Moles/volume] in Venous blood

302

1713

0.93

0.62

3.3

3.4

7.82

7.92

mmol/l

0.20

293

1688

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.52

0.61

1.1

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.60

0.61

1.0

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.47

0.58

1.0

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

135

0.74

0.58

1.1

1.3

1.94

1.44

mmol/l

—

(3013862) HLA-DP [Type]

1.66

0.56

1.0

—

(40760409) HLA-A [Type] by High resolution

1.66

0.56

1.0

—

(40760410) HLA-B [Type] by High resolution

1.66

0.56

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

341

1.16

0.56

1.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

341

1.16

0.56

1.3

1.6

—

(3012441) Differential panel - Pleural fluid

168

804

1.10

0.56

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

425

1.14

0.55

1.2

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

307

1509

1.07

0.55

1.8

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

370

0.85

0.55

1.2

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.50

0.55

1.2

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.58

0.54

1.3

1.1

—

(3017704) Immunofixation for Urine

347

1.15

0.54

1.2

1.5

—

(46236302) HLA-C [Type] by High resolution typing

1.58

0.54

1.0

—

(40763590) HLA-DQ beta [Type]

1.58

0.54

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.58

0.54

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

334

1649

1.07

0.53

2.0

2.6

126.73

113.13

ug/min

0.16

183

1051

(4281824) Cell count and differential, peritoneal fluid

576

0.89

0.53

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

321

1584

1.07

0.52

1.1

1.4

238.85

267.49

u/ml

1.02

188

1067

(3014891) Appearance of Pleural fluid

126

0.75

0.51

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

187

905

1.09

0.51

2.4

2.9

91.64

1267.99

u/ml

0.90

181

891

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.42

0.50

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

195

0.81

0.49

1.1

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

115

545

1.11

0.48

1.3

12.33

15.03

u/l

0.70

107

492

(3034426) Prothrombin time (PT)

233

1.18

0.48

1.4

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

148

711

1.10

0.48

1.4

6.16

6.46

mmol/l

0.79

138

666

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.60

0.48

1.4

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.58

0.48

1.4

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.58

0.48

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

321

1793

0.94

0.47

3.2

3.3

1.61

1.71

mmol/l

0.99

311

1761

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.50

0.46

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

143

1.22

0.44

1.4

1.9

1.18

1.17

mmol/l

0.90

137

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.45

0.44

1.1

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.45

0.44

1.9

1.8

21.36

22.02

mmol/l

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

163

0.81

0.43

2.0

1.9

—

(3008536) Aspergillus sp Ab [Presence] in Serum

134

1.22

0.42

1.9

3.0

—

(3019977) pH of Arterial blood

380

1.12

0.42

2.3

2.6

7.42

0.07

121

(3052592) Norovirus Ag [Presence] in Stool

145

0.80

0.42

1.4

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

208

0.83

0.42

1.1

1.8

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.40

0.41

1.3

1.0

—

(40768806) Pleura Pathology biopsy report

165

804

1.08

0.41

1.6

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

220

1236

0.94

0.41

4.5

5.8

343.95

380.72

umol/l

3.83

196

1104

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

121

1.22

0.39

1.8

1.9

135.89

163.36

ng/l

0.35

121

(46235168) Fasting glucose [Moles/volume] in Blood

102

1.24

0.39

1.1

3.4

5.91

7.40

mmol/l

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

496

2720

0.96

0.39

2.6

3.4

0.34

u/ml

0.04

273

1532

(3020876) Protein [Mass/time] in 24 hour Urine

164

802

1.08

0.39

2.2

2.6

1.59

1.34

g/24h

0.40

474

(3040151) Glucose [Moles/volume] in Capillary blood

175

858

1.07

0.38

5.5

18.2

7.39

7.43

mmol/l

0.06

143

707

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.64

0.37

1.0

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

113

545

1.09

0.37

1.4

11.79

13.40

umol/l

1.90

106

515

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.44

0.36

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

281

1404

1.05

0.36

1.7

2.9

0.88

0.81

nmol/l

0.80

233

1172

(3023383) Lactate [Moles/volume] in Pleural fluid

231

1.14

0.35

1.2

1.4

3.31

3.41

mmol/l

0.09

214

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

146

716

1.07

0.34

1.3

1.4

8.95

7.69

mmol/l

2.95

141

700

(3037692) Legionella sp identified in Specimen by Organism specific culture

242

1.13

0.33

1.2

1.7

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

0.78

0.33

1.1

1.3

23.87

87.45

u/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

255

1276

1.05

0.32

1.3

5.00

4.10

ug/l

0.28

239

1192

(3033705) Calcium.ionized [Moles/volume] in Venous blood

184

1028

0.94

0.32

2.3

2.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

308

1694

0.96

0.30

1.1

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

144

710

1.07

0.30

1.3

293.35

558.08

u/l

1.57

135

671

(3028308) Erythrocytes [#/volume] in Pleural fluid

168

834

1.06

0.29

1.5

1.4

87582.07

42680.38

e6/l

0.54

482

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.23

0.29

2.8

2.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

412

2248

0.96

0.29

2.2

3.0

3.65

3.57

g/l

0.40

386

2147

(3013762) Body weight Measured

1.28

0.28

1.0

1.2

—

(3022475) Manganese [Moles/volume] in Blood

1.24

0.28

1.0

1.2

—

(3022229) Phosphate [Moles/volume] in Urine

0.67

0.27

2.2

1.2

33.28

20.80

mmol/l

—

(3019174) dRVVT (LA screen)

1.27

0.26

1.2

—

(40758292) HTLV I+II Ab panel - Serum

108

0.83

0.26

1.1

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.19

0.26

1.6

1.9

2.26

2.82

ug/l

—

(3023199) Leukocytes [#/volume] in Pleural fluid

183

916

1.05

0.25

1.5

1664.75

1713.44

e6/l

0.05

121

657

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.22

0.25

1.2

39.00

37.17

—

(40758358) Immune stain study

1.39

0.24

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.26

0.24

2.3

5.5

—

(3039000) Anion gap in Blood

274

1499

0.96

0.24

5.5

7.4

11.21

11.28

mmol/l

0.14

245

1369

(3018572) Chloride [Moles/volume] in Blood

274

1499

0.96

0.24

5.5

7.4

105.37

105.00

mmol/l

0.77

245

1369

(3027923) C peptide [Moles/volume] in Serum or Plasma

335

1.08

0.23

1.7

1.5

1.21

1.17

nmol/l

0.10

272

(3020393) Adenovirus Ag [Presence] in Stool

1.23

0.23

1.0

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.22

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.22

0.0

3.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.22

0.0

1.2

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.22

0.0

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.22

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.26

0.21

1.8

2.0

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

151

758

1.05

0.21

1.3

1.7

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.21

0.20

1.0

1.1

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

151

759

1.05

0.20

1.3

1.7

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

1.23

0.19

2.7

1.6

1.43

1.97

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

421

0.94

0.19

1.1

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.22

0.18

1.1

1.0

—

(3045788) Cell count panel - Pleural fluid

142

716

1.04

0.17

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.17

0.17

2.9

2.1

0.67

1.33

mmol/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.20

0.17

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.14

0.16

1.3

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

245

0.92

0.16

1.5

1.53

2.59

1.03

204

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.18

0.15

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

102

0.88

0.15

1.4

27.72

23.96

0.15

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

140

709

1.04

0.15

1.1

1.2

97.37

90.64

2.21

132

676

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

389

1.06

0.15

2.6

2.8

44.50

38.34

2.09

203

(3007930) Methemoglobin/Hemoglobin.total in Blood

539

2889

0.98

0.15

4.1

5.3

0.88

0.87

0.11

509

2738

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.81

0.14

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

197

1009

1.03

0.12

1.2

1.4

7.28

6.87

mmol/l

1.08

174

871

(3034092) Cytoplasmic Ig cells/100 cells in Blood

111

0.90

0.12

10.6

5.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

219

0.94

0.11

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

219

0.94

0.11

2.5

—

(3051651) Icteric interference index of Serum or Plasma

428

0.96

0.11

2.8

4.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.89

0.10

1.7

2.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

416

1.04

0.09

1.2

1.3

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.05

0.09

1.0

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.88

0.08

6.9

4.9

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.12

0.08

1.2

1.3

—

(3017509) Phencyclidine [Presence] in Urine

0.91

0.08

1.2

2.5

—

(3035880) pH of Pleural fluid

430

0.97

0.08

1.3

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

618

3221

1.01

0.08

3.7

4.5

47.17

47.82

0.25

609

3186

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

217

1163

0.98

0.08

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

0.81

0.08

1.0

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.11

0.08

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

146

0.94

0.07

1.7

1.9

1.19

1.18

mmol/l

0.16

141

(40765089) Chromosome analysis panel - Blood by G-banded

365

0.97

0.07

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.08

0.07

1.3

2.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.03

0.07

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.84

0.07

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

129

1.06

0.06

1.7

1.5

4.93

12.93

1.70

(3000034) Microalbumin [Mass/volume] in Urine

110

592

0.98

0.06

3.2

29.48

73.42

mg/l

1.89

428

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

207

1.04

0.06

2.8

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1979

10459

1.00

0.06

1.7

1.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

550

2919

0.99

0.06

4.1

5.2

1.68

1.64

0.38

521

2763

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

347

0.97

0.05

2.6

3.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

112

0.94

0.05

1.1

1.3

5.36

0.97

mmol/l

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

521

0.98

0.05

1.5

2.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

196

1045

0.99

0.05

1.6

1.5

31.80

30.51

g/l

0.74

173

920

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.06

0.04

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

120

1.05

0.04

1.0

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

132

0.96

0.03

1.4

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

384

2011

1.01

0.02

2.6

3.1

177.37

190.71

2.15

365

1927

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

353

0.98

0.02

1.2

1.1

1593.79

1515.38

miu/ml

0.22

353

(3051593) INR in Capillary blood by Coagulation assay

359

1.01

0.01

8.8

15.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.96

0.01

1.3

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

112

586

1.01

0.00

1.6

1.9

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.96

0.00

1.1

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.96

0.00

1.1

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

414

2183

1.00

0.00

2.1

2.8

92.63

91.11

0.74

400

2117

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.97

0.00

1.2

1.0

35.62

49.55

mg/l

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

1.03

0.00

2.8

2.7

671.26

1369.15

u/l

0.39

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

278

1.00

0.00

1.5

62.05

65.84

0.32

223

(3027273) Bicarbonate [Moles/volume] in Venous blood

672

3537

1.00

0.00

3.1

4.2

25.11

24.94

mmol/l

0.63

647

3428

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.97

0.00

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.02

0.00

1.2

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.95

-0.00

1.1

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.90

-0.00

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.88

-0.00

1.0

2.5

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_COXIBS – Coxibs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Coxibs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Coxibs (RX_COXIBS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints